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The upregulation of inflammatory mediators in the tear film during contact lens wear 
indicates that lens wear may induce an inflammatory response on the ocular surface. Previous 
research has investigated the relationship between lens wear and ocular inflammation through 
analyses of cytokine levels in tear samples. However, there has been little discussion regarding the 
interaction between contact lens materials and cytokines, and its role in ocular inflammation. This 
thesis aimed to study the release of cytokines from contact lens materials. Particularly, to 
determine whether the release of cytokines differed between silicone hydrogel and conventional 
hydrogel contact lens materials.  
 
Materials and Methods:  
 
The contact lens materials investigated in this thesis include hydrogel (etafilcon A; omafilcon 
A) and silicone hydrogel (delefilcon A; somofilcon A) materials. Lens materials were incubated 
in a combined cytokine solution that contained ten recombinant human cytokines. The cytokines 
of interest for this study were: IL-1β, IL-6, IL-8, and TNF-⍺. 
• Chapter 3: A protocol to aid in quantifying cytokines released from contact lens materials 
was developed. To determine the parameters of the protocol, the effects of changing 
temperature, incubation period, and volume of diluent 2 on the amount of cytokines 
released from lens materials were analyzed. Cytokines present in samples were quantified 
using the Meso Scale Discovery (MSD) cytokine assay.   
• Chapter 4: The protocol developed in chapter three was used to determine whether the 
release of cytokines differed between contact lens materials that were pre-exposed to 
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various ocular conditions. The ocular conditions tested were: 1) contact lens materials 
incubated in a high cytokine concentration solution; 2) contact lens materials incubated in 
a cytokine solution for a 12-hour period; 3) contact lens materials incubated in a cytokine 
solution at 34℃. 
• Chapter 5: Contact lens materials were first incubated in a single protein solution 
(lysozyme, lactoferrin, or albumin) for 16-hours. Post incubation, lens materials were 
soaked in a cytokine solution for a 6-hour period.  The protocol developed in chapter three 
was then used to determine whether the release of cytokines differed between protein-




In chapter three, the parameters for the protocol were set and the finalized protocol 
involved incubating cytokine-adsorbed contact lenses in 550μL of diluent 2 for 1 hour at room 
temperature. In chapter four, the difference in the release of cytokines between delefilcon A and 
etafilcon A lenses was tested, and it was observed that when the lenses were incubated in a high 
cytokine concentration solution, etafilcon A released more IL-1β than delefilcon A. In chapter five, 
it was found cytokine release did not differ between protein-coated delefilcon A and etafilcon A 
lens materials.   
 
Conclusion: 
This thesis contributes to existing knowledge of ocular inflammation related to contact lens 
wear by providing an insight into lens materials’ ability to release IL-1β, IL-6, IL-8, and TNF-⍺.  
Future research studies should investigate the effect of released cytokines on the ocular surface.   
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Chapter 1: Literature Review 
1.1 Cornea  
The outer tunic of the eye, shaped like an asymmetric globe, is composed of the cornea and 
sclera.1,2 Approximately 85% of the outer tunic is comprised of the opaque sclera, with the 
remaining 15% made up of the transparent cornea.1 Both structures meet at a region called the 
limbus to form the outer coat of the eye.1  These components act as a structural barrier to enclose 
other ocular contents as well as provide protection.1,3 The ability of the cornea and sclera to 
withstand both intraocular pressure as well as any force exerted onto the eye during ocular 
movements is made possible through its structure.1 Both components are made of connective tissue 
containing collagen fibrils, however,  it is the difference in the arrangement of the collagen fibrils 
that allows for one to appear transparent and the other to be opaque.1  
 
The collagen fibrils in the cornea are small and laterally arranged with a high level of 
organization. Essentially, the role of the cornea is to refract and transmit light.2  Refraction of light 
is dependent on the curvature of the anterior and posterior corneal surface, the refractive index as 
the medium changes from tear film to cornea and then from cornea to aqueous humor, and the 
thickness of the cornea.2  It is important for the cornea to maintain a smooth precise curvature 
shape as it, along with the tear film that lays on top of it, forms the main refractive component of 
the eye.1 On the contrary, the collagen in the sclera contains wider fibrils and lacks organization 
in its arrangement; rather, it follows a more interwoven pattern and thus is opaque in appearance. 
This appearance allows for prevention of internal light scatter.1 While the sclera does not 
necessarily have an optical function, mechanically it is responsible for providing attachment sites 
for extraocular muscles, withstand any movement induced by internal and external forces and 
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maintain the shape of the eye.1,2 Physiologically, it helps maintain ocular pressure by allowing 
aqueous humour to flow out through outflow channels.1  
 
The cornea is made up of 5 layers: corneal epithelium, Bowman’s layer, stroma, 
Descemet’s membrane, and the corneal endothelium.2 The epithelium is on the anterior portion of 
the cornea and it is in direct contact with the tear film, while the endothelium is on the posterior 
side and it faces the anterior chamber.2 The stratified corneal epithelium is a multi-cell layer 
consisting of nonkeratinized squamous cells on the surface, with wing cells and basal cells beneath 
it.2,3 The surface layer of the cell membrane is 2-3 cell layers thick. They consist of cells that are 
flat and polygonal in shape.4 Surrounding each cell are apical microvilli and microplicae which 
are coated in a layer of glycocalyx.4,5 The projections present on these cells increase the surface 
area to which the mucinous layer can adhere and thus lay closely along the cell membrane.4 While 
substances from the tear film are able to travel through the cells, any movement between the cells 
is prohibited.2,4 The apical cell layer is held closely together via tight junctions and desmosomes 
along the lateral walls of the cells to prevent the movement of tears within intercellular spaces.2,4   
The mid-layer of the epithelium is made of wing cells and is about 2-3 layers thick. Wing cells 
have lateral processes and are also held together by tight junctions.  Finally, the basal cell layer is 
a single cell layer of columnar epithelium cells.  The basal cells are capable of undergoing 
mitosis.4,6 The only other cells in the epithelium that can do so are the stem cells and the transient 
amplifying cells.4 As they undergo mitosis, they give rise to the wing cells present in the middle 
layer.2,4 Basal cells secrete a basement membrane below it,  and it is attached via a hemidesmosome 
system.2,4 Anchoring fibrils travel through the hemidesmosomes to help hold the basal epithelium 
to Bowman’s layer and the stroma.2,7  It is important for there to be a tight attachment between the 
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tissue layer and the corneal epithelium as any breakage in the system could lead to corneal erosion 
syndromes or epithelial defects.4   
 
The layer beneath the epithelium, Bowman’s layer, is a nonregenerative acellular layer 
comprised of collagen fibrils and proteoglycans.2-4 While it is not a true membrane, its main role 
is to help the cornea hold its shape.2-4 The next layer is the corneal stroma, which makes up about 
80-85% of the cornea. The precise arrangement of the bundles of collagen fibrils into parallel 
layers contributes to its transparency.4,8 Aside from the fibrils, the stroma also contains keratocytes 
and ground substances such as proteoglycans which helps maintain the tensile strength of the 
cornea.2 
 
 The next layer is Descemet membrane, which is also known as the basement membrane 
of the endothelium layer.2 The endothelium is a single-cell layer made of flattened cells.2 In order 
for the stroma to remain transparent, it needs to be in a state of dehydration.4 To help with its 
maintenance, the endothelial cells have a pump-leak system through which fluid flows from the 
stroma, past the endothelial cells and into the aqueous humour.4 This process is possible via an 
osmotic gradient created between the hypo-osmotic stroma and the hypertonic aqueous humour.4 
The organization and composition of the cornea is crucial in order for it to refract and transmit 
light effectively.2 
 
1.2 Tear Film 
The ocular surface that comes into contact with the environment is exposed to air pollution, 
various pathogens and the consequences that come with the change in air temperature9 and 
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humidity9.10 To protect the eye against these risk factors, the outer eye is covered by a liquid layer 
known as the tear film.10 The tear film is quite important to the visual system. Its responsibilities 
include moisturizing the conjunctiva and the cornea;11 and nourishing the cornea with its required 
nutrients12.13  Aside from protecting and hydrating the cornea, the tear film is also the first refractive 
surface light hits and thus it is important for it to be smooth in texture.14  
 
The tear film is broadly made up of three layers: the outer lipid layer, aqueous layer, and 
inner mucous layer.14 The outermost layer lying along the eye-air interphase, commonly known as 
the Tear Film Lipid Layer (TFLL), is biphasic as it has both a thick non-polar and a thin polar 
phase.10,15 The polar phase lies on the inner side of the TFLL and is created by phospholipid 
molecules. Meanwhile the nonpolar phase sits on the outer side and is predominantly composed 
of nonpolar lipids such as wax esters, sterol esters, hydrocarbons, and triglycerides.15 Primary 
functions of the TFLL include reducing surface tension of the tear film;10 preventing evaporation 
of the aqueous layer;10,15 ensuring tears remain on the ocular surface without spilling over; 10,15,16 
and preventing sebaceous lipids from interacting with the tear film.15,17  While evaporation of the 
tear film is influenced by the nonpolar phase, it is the composition and stability of the polar phase 
that allows for it to hold its function.15,18  The polar phase of the TFLL contain amphipathic 
phospholipid molecules which align themselves along the aqueous–lipid interface, allowing for 
the interaction between nonpolar lipids and aqueous lipids.15 This interaction helps to reduce 
surface tension between the tear film and air, eventually reducing evaporation.19  
 
The layer below the lipid layer is the aqueous layer, which forms the majority of the tear 
film’s thickness.20,21 With 98.2% of it being water, the remaining 1.8% of it are solids.13,22 
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Components of the aqueous phase are produced from the lacrimal gland20,23 and the accessory 
glands of Krause and Wolfring with contributions also from epithelial cells lining the ocular 
surface.20 This phase also acts as a transfer medium for nutrients, such as inorganic salts, glucose, 
and oxygen to travel to the cornea.13,20,22 The proteins, peptide growth factors, vitamins, 
inflammatory response markers, and hormones all have crucial roles in this aqueous phase.20 The 
composition of the tear film is quite important, as the ions help maintain the epithelial cells lining 
the ocular surface.15,24 The aqueous phase holds several electrolytes, which help create a buffer 
solution to maintain the tear film pH level.15,25 These electrolytes include sodium, potassium, 
magnesium, calcium, and bicarbonate.15 They also contribute to the osmolality of the tear film.15,26 
Consequences of hyperosmolarity include damage to the ocular surface, as well the development 
of dry eye syndrome.15,20,27 Proteins also have a prominent role in the tear film as they assist with 
ocular defense mechanisms28 and tear film stability.20,29 Some of the more abundant proteins found 
in the tear film include lysozyme, lactoferrin and lipocalin. In the case of an inflammatory 
response, the tear film will also contain various inflammatory markers which respond to situations 
such as irritation occurring on the ocular surface or epithelial cell dysfunction.20,30   
 
The innermost tear film layer lying along the cornea and tear film interface is the mucous 
layer.13 The components of this layer are mainly secreted by the conjunctival goblet cells with 
contributions also made from the corneal and conjunctival epithelium.13 When stimulated, 
conjunctival goblet cells release mucin and glycoproteins onto the cornea.13 Components of the 
mucous layer include mucin, immunoglobulins, urea, salts and enzymes.13,31 The mucins make the 
relatively hydrophobic cells of the conjunctiva and cornea hydrophilic, which then allows for the 
aqueous layer to spread across the corneal epithelium.13 Ocular mucins in particular are responsible 
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for preventing the adherence of bacteria to the corneal epithelium.13 Prevention can occur through 
one of two mechanisms. In one scenario, mucin have the ability to directly bind to the bacteria and 
thus prevent it from adhering to the epithelium.13  On the other hand, mucin can also competitively 
bind to microbial receptors and prevent adherence that way.13,32 All the components of the mucus 
come together to provide lubrication to the cornea, defend it against shear forces, and aid in 
stabilizing the tear film.13 
 
While the tear film does have 3 layers, a deeper analysis into the composition of the mucin 
layer found that there exists a blend between the aqueous and mucin layer.14 This resulted in 
recognizing it as a single layer, thus referring to it as the muco-aqueous layer.14  Consequently, the 
tear film is recognized to be bi-phasic in nature, with its components being the lipid layer and the 
muco-aqueous layer.14  
 
The composition of the tear film is not always consistent. Due to its high responsiveness 
to ocular conditions, researchers have analyzed its biochemical properties under these conditions, 
and that has helped understand what causes disease.33  The lacrimal gland plays an important role 
in protecting the health of the ocular surface, as it secretes antimicrobial molecules such as 
lactoferrin, lysozyme, lipocalin toll-like receptors, and immunoglobulins (Ig) such as IgA and IgG 
into the tear film.33,34 Secretary IgA (sIgA) has a crucial role in the adaptive immune response 
which is responsible for specific immunity.33 sIgA is a primary immunoglobulin, also commonly 
referred to as an antibody, which helps to protect against any microorganism that may contact the 
eye.13,33,35 In the case that there are bacteria present on the ocular surface, the sIgA binds to the 
bacteria and stimulates polymorphonuclear leucocytes (PMNs) to conduct phagocytosis to remove 
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the bacteria from the surface.35 sIgA acts on bacteria by also creating a coat which results in 
bacterial agglutination and the bacterial molecules are then neutralized and lysed.13,36,37 As a result, 
bacteria can no longer bind onto the corneal epithelial cells.13,36,37 During an infection it is common 
to see an increase in specific antibodies, and their presence can be indicative of certain ocular 
diseases.33 For example, increased levels in IgA, IgG and IgM can be associated with ocular 
infections such as acute adenoviral conjunctivitis and acute bacterial conjunctivitis.33   
 
Another important factor in the immune system, present in the tear film are the Toll-Like 
receptors (TLRs).33 TLRs are located on the corneal epithelial cells and are responsible for 
recognizing specific pathogen-associated molecular patterns (PAMPs).33 PAMPs are molecules 
whose structures have been conserved through evolution and are frequently present in similar 
pathogens.33,38 The presence of these molecules initiates adaptive and innate immune responses.33,38  
Commonly found PAMPs in the tear film are flagellin, peptidoglycan, lipoteichoic acid, and 
lipopolysaccharide.33,39 Once the TLRs are activated by the PAMPs, they initiate an immune 
response by signaling for the upregulation of cytokines and chemokines which are both protein 
molecules.33 These molecules then signal for inflammatory cells to migrate to the site of infection 
to fight it.33  Ocular disorders in which TLRs have been found to have a role, include herpes 
simplex keratitis, Sjogren’s syndrome dry eye, and non-Sjogren’s syndrome dry eye.33  
 
1.3 Proteins in the tear film: 
1.3.1 Cytokines  
 Cytokines are small molecular proteins, which are responsible for relaying the 
communication and interaction between cells.40,41  Although they are secreted by most nucleated 
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cells 41, the primary sources are helper T cells (TH) and macrophages.40 While “cytokine” is the 
general term used to classify these proteins, terms such as lymphokine, monokine and interleukin 
(IL) are also used, as these names provide a direct indication of which cell secreted them.40,41  For 
example, an interleukin is secreted by leukocytes.40 The production of cytokines often happens 
through a cascade.40 Once the initially released cytokine signals its target cell, that cell then 
activates its cytokine gene expression, leading to the production of various cytokines.40 These 
cytokines will then act similarly to signal other target cells and lead to the production of additional 
cytokines, and so on.40 When referring specifically to inflammation, cytokines for the most part 
can be divided into two categories: proinflammatory (promoting inflammatory responses) and anti-
inflammatory (preventing the proinflammatory cytokine activity).40,41  The balance between both 
inflammatory responses heavily influences disease management in an individual.33,41 
   
 Proinflammatory responses are primarily regulated through the presence of IL-1 (a and b) 
and tumour necrosis factor (TNF) (a and b),  as they collectively activate cytokine expression by 
acting on the endothelium.41,42 When macrophages or monocytes are triggered by stimuli such as 
cell injury they secrete IL-1a and b, which then act on IL-1 receptors (IL-1R)  to induce 
inflammatory responses.40,43,44  While the IL-1a gene is constantly transcribed and produced in its 
31 kDa pro-form, the production of IL-1b requires cells to be exposed to pathogen- or damage-
associated molecular patterns (PAMPs or DAMPs).44,45 This exposure then leads to the secretion 
of IL-1b (35kDa) in its inactive pro-form.44 The activation of IL-1b involves inflammasomes. 
Inflammasomes are protein complexes whose components include: a sensor, adaptor and 
procaspase-1.46 In the presence of PAMPs and DAMPs, inflammasomes are constructed which 
then go on to activate caspase-1enzyme (CASP1/ICE).43,46  Caspase-1 then cleaves the pro-IL-1b 
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into its active 17 kDa form.44,46 Once in its active form, IL-1 then goes onto regulate the secretion 
of several other cytokines such as IL-6, IL-8, and TNF-⍺.47,48  
 
 While IL-1b and TNF do act synergistically, IL-1b is also involved in the regulation of its 
secretion.33,48,49 Pro-TNF (26 kDa)50 is a transmembrane protein that is cleaved into soluble TNF 
(17 kDa) via the TNF-a-converting Enzyme (TACE).50 Soluble TNF has the ability to travel 
through blood plasma, thus acting on sites far from the location where it was produced.50  TNF-a 
acts on the receptors TNFR140 and TNFR240 to regulate immune responses and increase pain 
sensitivity.40,42 
 
Another prime cytokine that is often investigated in the tear film is IL-6, as it has a role in 
ocular inflammation.51 While several cells are capable of producing IL-6, such as monocytes, 
vascular smooth muscle cells and osteoblasts, there are only a limited number of cells that express 
the receptor for IL-6.51 These include macrophages, neutrophils, and some T-cells.51 Aside from 
IL-6 (21-28 kDa) being involved in the differentiation of both B-cells and T-cells, it can also 
stimulate lymphocyte chemotaxis.51 Similarly, another common cytokine that plays a crucial role 
in ocular inflammation is IL-8.52 IL-8 is recognized as a chemokine, with a molecular weight of 8-
10 kDa.52 Due to its ability to promote proinflammatory responses, its production is maintained at 
a minimum and thus in healthy tissues, its levels are usually low or undetectable.52,53 Similar to 
many cytokines, IL-8 is also produced by monocytes and macrophages. IL-8 is a commonly used 
chemotactic factor in the immune system. Its presence induces chemotaxis and thus directs the 
movement of neutrophils, basophils and T lymphocytes to sites of inflammation.52 Aside from 
recruiting immune cells, it also has a role in cell adhesion, angiogenesis, and protecting neurons.52  
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1.3.1.1  Cytokine Concentrations in Human Tears 
 
 Several studies investigating inflammatory cytokine levels in human tears under various 
conditions have been carried out. In a study which set out to determine IL-1a, IL-1b, IL-6 and IL-
8 levels in normal human healthy tears, Nakamura et al. collected tear samples from 270 healthy 
participants.54 Both basal tears (mean of 9µL) and reflex tears (mean of 115 µL) were collected 
from each eye.54 Cytokine levels were quantified using an enzyme-linked immunoassay (ELISA) 
and it was reported that IL-1⍺ levels (mean ± SEM) were 10.9 ± 1.2 pg/mL and 9.3 ± 2.7 pg/mL 
in basal and reflex tears, respectively. Levels of IL-6, IL-8 and IL-1β in basal tears were reported 
to be 226.2 ± 29.6 pg/mL, 731.4 ± 116.2 pg/mL, and 12.9 ± 2.3 pg/mL, respectively.54  Meanwhile 
in reflex tears, IL-6 and IL-8 levels were reported as 11.6 ± 1.6 pg/mL and 276.1 ± 47.5 pg/mL, 
respectively.54 IL-1β levels in reflex tears were not detectable.54 The purpose of these results and 
this study was to provide a baseline for normal human tear cytokine concentrations so that they 
could be used as a comparison when analyzing tears from participants with ocular diseases.54  
 
 With a similar purpose, a study by Carreño et al. was conducted to determine the 
concentration of 30 cytokines and chemokines in tears from healthy subjects.55 Nine participants 
with no previous history of ocular disease were recruited and tear samples were collected from 
each eye.55 Samples were then analyzed through a multiplex bead analysis using the Luminex IS-
100.55 While 30 cytokines and chemokines were analyzed, only 25 of them were detected in the 
samples.55 Some of the cytokine concentrations reported include a mean concentration of 47.5 ± 
3.3 pg/mL, 101.4 ± 2.8 pg/mL, 130.4 ±12.3 pg/mL and 322.7 ± 33.5 pg/mL for TNF-⍺, IL-1β, IL-
6 and IL-8 respectively.55  
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 One study by Thakur et al., investigated the difference in cytokines and lipid inflammatory 
mediators between tears in closed eyes and open eyes.56 In the absence of blinking, which is usually 
when a person is sleeping, the rate of tear flow is reduced. Previous research found that PMNs 
such as neutrophils were being recruited into tears upon eye closure.56,57 The method of recruitment 
however was not clear.56 Thakur et al. predicted that since IL-8 was a known neutrophil chemokine, 
it was being produced when the eyes were closed. Apart from IL-8, leukotriene B4 (LTB4) is also 
chemoattractant for neutrophils.56 It was hypothesized that while the eyes were closed during sleep, 
there was an upregulation of cytokines and lipid inflammatory mediators.56 As a result, PMNs were 
recruited and the production of IgAs were increased.56 To test this hypothesis, participants with no 
reported ocular infections were recruited and their open-eye tears and closed-eye tears were 
collected.56 Tears for the closed-eye study were collected after 3, 5, and 8 hours of sleep.56 
Cytokines and lipid inflammatory mediators were quantified using ELISA kits. It was reported 
that there was a significant increase in IL-8 and LTB4 levels in closed-eye tears after 8 hours of 
sleep in comparison to open-eye tears (P < 0.0001).  Levels of IL-8 were found to be significantly 
higher in tears collected at 8 hours of sleep versus 3 hours (p < 0.008).56 IL-6 levels were reported 
to be 147.0 ± pg/mL in closed-eye tears and below the limit of detection in open-eye tears.56 Levels 
of IL-1β were not detected in both closed- and open-eye tears.56 The results from their study 
showed that the upregulation of cytokines and arachidonic acid metabolites stimulated the 
migration of PMNs into the tear film.56  It is predicted that granulocyte macrophage colony 
stimulating factors (GM-CSF) activate these PMNs which then allows for them to express IgA 
receptors.56  Through the expression of these receptors, PMNs then have the opportunity to engulf 
debris or microorganisms present on the ocular surface.56  
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 Cytokine concentrations can also vary depending on ocular conditions. A study by 
Massingale et al. was set out to determine the correlation between cytokine levels and tears of 
patients with dry eye disease (DED).47 Non-stimulated tears (20 μL) were collected from one eye 
from seven healthy participants and seven participants with DED.47 The tears were then analyzed 
using Invitrogen’s Multiplex Bead Immunoassay, which uses flow cytometry, for a total of 8 
cytokines and 1 chemokine.47 Results showed that there was a significant increase in the 
proinflammatory cytokines IL-6, IL-1β and TNF-⍺ and the chemokine IL-8 in tears from DED 
participants (1625.7 ± 430.9 pg/mL, 664.3 ± 148.8 pg/mL, 435.7 ± 145.6 pg/mL and 48508.6 ± 
9397.3 pg/mL, respectively)  in comparison to tears from healthy participants  (632.3 ± 167.9 
pg/mL, 436.3±116.7 pg/mL, 25.06 ± 63.2 pg/mL and 16791.4 ± 2841.2 pg/mL, respectively).47  
From this study they concluded that inflammation has a role in DED and the extent of it is 
dependent on the degree of the disease.47 In addition, they reported that increased tear 
inflammatory markers concentration while the eye is in DED state, is due to its upregulation rather 
than tear film evaporation.47 
 
Another ocular condition investigated by researchers interested in cytokine levels was 
keratoconus.58 Lema et al. conducted a study to quantify the levels of cytokines, cell adhesion 
molecules, and matrix metalloproteinase 9 (MMP-9) in patients with keratoconus.58 The cytokines 
of interest were IL-4, IL-6, IL-10, and TNF-⍺.58 Both, patients with keratoconus and normal 
healthy subjects, were recruited. Tear samples were collected from the inferior meniscus and 
analyzed using an enzyme-linked immunoadsorbent assay kit.58 The results from the study showed 
that while there was no significant difference between the  levels of IL-4 and IL-10 in both 
keratoconus tears and normal tears, significantly increased levels of IL-6 and TNF-⍺ were found 
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in patients with keratoconus (values reported as median [quartiles]) (6.7 [4.8-10.8] pg/mL and 3.8 
[2.9 – 14.4] pg/mL, respectively) in comparison to normal tear samples (2.2 [1.0 -4.1] pg/mL and 
1.8 [ 1.5-2.3] pg/mL, respectively).58 The results also showed that MMP-9 levels were significantly 
higher in keratoconus tears (66.5 [49.2-139.3) ng/mL) in comparison to the normal tears (6.1 [3.9 
-8.3] ng/mL).58 While the roles that these cytokines play in keratoconus were unknown, it was 
concluded that with an increase in IL-6, TNF-⍺ and MMP-9, inflammatory events take place on 
the ocular surface in patients with keratoconus.58 
 
Together, all the studies mentioned above show that inflammatory events on the ocular 
surface can be induced by various ocular diseases and conditions.  In addition, there is no definitive 
basal level of tears present as the results in these studies varied due to the methods used to collect 
tears; participant demographics; and the equipment and assays used to quantify the cytokines from 
the samples.  
 
1.3.2 Major Tear Film Proteins 
 Amongst the many proteins in the tear film, lysozyme, lactoferrin and albumin are most 
commonly investigated proteins in contact lens and dry eye studies.   
 
Lysozyme (14.3 kDa, pI pH 11.4 59) is another commonly found protein in the tear film as 
it constitutes approximately 20-30% of the total protein concentration found in the tears.60-62 This 
protein molecule has enzymatic antimicrobial properties and has the ability to kill gram positive 
bacteria through lytic activity.60,61,63,64 Bacterial cell walls are composed of peptidoglycan, which 
consists of 1,4-beta linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine.60,61,64,65  
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Lysozyme breaks the 1,4-beta linkage, which compromises the state of the cell wall.60 This leads 
to an increase in internal osmotic pressure which eventually results in the lysis of the bacteria.60  
 
Lactoferrin (pI pH 8.7 59) is a glycoprotein63 with a molecular weight of 82 kDa.66 By 
weight, it makes up approximately 25% of the total protein found in tears, with tear concentration 
levels reported to be 2.2 mg/mL.66,67 While the main source of secretion is the acinar cells found 
in the lacrimal gland61, the epithelia on the ocular surface can produce lactoferrin as well.66,68 In 
the tear film, lactoferrin can have both anti-microbial and anti-inflammatory properties.66 Bacteria 
require iron for growth, and lactoferrin inhibits bacterial growth by binding to the free iron 
molecules in the tears.63,66,69 In addition, lactoferrin is also a positively charged molecule at the 
physiological pH.66 This property thus allows for it to bind onto negatively charged molecules 
present on the surface of both gram-negative and gram-positive bacteria. As a result, the cell wall 
of the bacteria is often compromised.61,66  
 
Albumin (66 kDa 70,71) is a negatively charged serum protein that has a pI pH of 5.2.59  It is 
produced by the hepatocytes in the liver.70,71 As a small molecular protein, it has the ability to cross 
the blood-tear barrier. Its presence in the ocular environment is thus used to indicate the 
permeability of the vasculature.71 Its duties include acting as a transport protein to deliver 
physiological molecules such as hormones, fatty acids and drugs.70-72 It also has a role in stabilizing 
the blood pH levels as well as its osmotic pressure.70 Reported albumin levels in the tear film 
ranges from 0.0103 mg/ml to 390 mg/ml.70,73  Its concentration can vary depending on ocular 
conditions. For instance, higher levels of albumin can be seen in patients with symptoms of dry 
eye or in those who wear contact lens.70   
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1.4 Contact lenses 
1.4.1 Contact Lens Background and History 
 Contact lenses are biomaterials primarily used as a medical device to correct refractive 
errors74,75, which are worn by over 125 million people globally.75 The demand for the use of contact 
lenses goes beyond the purpose of solely using them for correcting vision.  With the advancement 
in research, contact lenses have been used to provide therapeutic uses such as acting as a vehicle 
to deliver drugs to treat ocular conditions such as glaucoma 75,76 and acting as a bandage to treat 
corneal diseases such as corneal epithelial disorders.77 Another common eye condition that is 
estimated to affect over 1400 million people around the world is myopia.75,78 The growing interest 
in myopia control have led researchers to develop contact lenses which can slow progression of 
myopia.75,79  
The concept of using contact lenses was first introduced by August Muller in 1889. His 
idea was that in order for the lenses to be held in place against the surface of the eye, the shape of 
the lenses should follow that of the outer surface of the eye.74 The first set of contact lenses that 
were fitted to a patient was made of a protective glass shell and were referred to as glass scleral 
lenses.74,80 These lenses did have their limitations as they were large and allowed only limited tear 
flow beneath the lens.74,80 Improvements to the lens model was done by introducing plastics as a 
material to develop lenses. After trying cellulose nitrate, cellulose acetate and polyvinyl acetate81, 
in 1938, polymethyl methacrylate (PMMA) was used to make scleral lenses.74,80,81 Lenses that 
were made of PMMA were often referred to as hard lenses.75 While they were light in weight, 
these lenses were limited in their hydrophilic properties and did not offer oxygen permeability75, 
which led to corneal hypoxia.74,75,82    
In an attempt to create a lens material that offered greater biocompatibility with the eye, 
hydrogel soft lenses were invented in the early 1970’s.83 The initial hydrogel material was 
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fabricated from hydroxyethyl methacrylate (HEMA) which were hydrophilic and were the first 
contact lens materials to absorb water.75 While lenses made from HEMA were successful, they did 
have their drawbacks as they did not offer enough oxygen permeability.75 The need to improve 
oxygen permeability led to the eventual development of silicone-based hydrogel lenses. Oxygen 
is highly soluble in silicone, so the incorporation of silicone into hydrogel lenses eliminated a lot 
of hypoxia-related ocular conditions.83 These lenses offer the highest oxygen permeability when 
compared to all other materials.75 Conversely, silicone is inherently hydrophobic in nature.83 The 
hydrophobicity caused by silicone led to poor lens surface wettability.75,83 To improve the 
wettability and add hydrophilicity to the lens, hydrophilic co-monomers were incorporated into 
the silicone material.75,83  
 
1.4.2 Contact Lens Classification 
 In 1994, The United States Food and Drug Administration (FDA) issued a document that 
that categorized conventional contact lenses according to two physical properties: water content 
and ionic charge.84 The grouping system that was developed is shown in Table 1:  
Table 1.4-a: Classification of conventional hydrogel contact lens issued by the FDA84 
Group Water Content Ionic Charge 
I  Low – water content Non-ionic lenses 
II  High-water content Non-ionic lenses 
III Low-water content Ionic lenses 
IV  High-water content Ionic lenses 
 
 Due to the incorporation of monomers and silicone macromers into silicone hydrogel 
contact lens, a separate grouping system was assigned for silicone hydrogel lenses.84 The 
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classification of silicone hydrogel lenses is also dependent on water content (low-water versus 
high-water content) and ionic charge (non-ionic versus ionic).84  However, the low-water, non-
ionic group is further subdivided into three categories.  The subdivision allows for predictions to 
be made with regards to how the lens material interacts with human lipids and whether the lenses 
have any surface treatments present.84 As seen in Table 1.4-b, lenses that are low-water, and non-
ionic can be placed into group V-A, V-B1 and B2. While lenses that are surface treated are placed 
into group V-A, non-surface treated lenses are placed into group V-B, which is then subdivided 
into V-B1 and V-B2.84 Non-surface treated V-B lenses that contain hydrophilic monomers are 
placed into V-B1, and non-surface treated V-B lenses that contain a semi-interpenetrating network 
are placed into V-B2.84  
Table 1.4-b: Classification of silicone hydrogel contact lens84 
Group Water Content Ionic Charge 
V - A Low-water content Non-ionic 
V - B1 Low-water content  Non-ionic 
V - B2 Low-water content Non-ionic 
V - C High-water content Non-ionic 
V - D Both low-water and high-water content Ionic  
 
 The grouping system allows for researchers and product developers to predict and 
understand how contact lenses will interact with tear film components and preservatives, in terms 
of uptake and release.84  
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1.4.3 Contact Lens Discomfort 
 Although wearing contact lenses has its benefits, there are several disadvantages which can 
lead to the discontinuation of lens wear. One such disadvantage is discomfort. Contact lens 
discomfort (CLD) is a condition defined by unfavourable ocular sensations due to the lack of 
compatibility between the eye and contact lenses.85  CLD may result in visual disruptions, leading 
to the discontinued use of lenses or decreased wearing times.85 Symptoms of CLD that have been 
reported include: dryness, blurry vision, scratchiness, irritation, light sensitivity, and eye 
soreness.86,87 While environmental and lens property factors have been reported to be causes of 
CLD, researchers have also proposed that CLD may be a response to sensitivity relayed by the 
neural terminals present on the ocular surface.88 For example, changes to tear composition such as 
an increase in proteins can be interpreted as a chemical stimuli by a neuroreceptor.88 In addition, 
mechanoreceptors and thermoreceptors can become stimulated due to an increased interaction 
between the ocular surface and lenses and an increase in ocular temperature due to inflammatory 
responses, respectively.88 In fact, a study was conducted investigating the relationship between the 
level of ocular inflammation present during contact lens wear and the level of discomfort felt by 
lens wearers. Amongst the various cytokines analyzed, it was reported that CLD was associated 
with an increase in IL-17A levels in contact lens wearers.89 The discussion around CLD and the 
mechanism that induces it has led researchers to study whether CLD is a result of subacute 
inflammation. 
1.4.4 Contact lens and Corneal Infiltrative Events 
Contact lens-related corneal infiltrative events (CIE) have been of interest to clinicians and 
researchers for several years as its occurrence in contact lens wearers has been increasing in recent 
times.90,91 When inflammatory responses are initiated on the ocular surface, inflammatory 
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mediators are released which then signal for the infiltration of white blood cells and other PMNs 
to the site of injury.92 The term CIE thus refers to the accumulation and aggregation of 
inflammatory cells on the cornea due to an inflammatory response.92,93 The term infiltrate refers to 
any cell, fluid, or substance that has travelled into the gaps present in tissues or cells.94 These 
infiltrates can be characterized as small, round, or shapeless, hazy-coloured clumps of 
inflammatory cells present on the corneal surface.93 While the categorization of CIEs has been 
challenged, the proposed grouping of CIE is: sterile vs infectious keratitis.90,92  
 
Microbial keratitis (MK) is a form of ocular inflammation which is caused by microbes 
such as bacteria and fungi present on the ocular surface.95 Once these microbes make their way 
into the corneal stroma they can cause inflammation which in extreme cases can lead to structural 
damage.95,96 Some risk factors that can lead to MK include: contact lens wear (particularly both 
overnight and extended wear), poor lens disinfecting practices, ocular surgery, etc.95 As a result of 
MK, patients often experience redness, tearing and blurry vision 95, severe hyperemia 93, and tissue 
necrosis.93 
 
 Sterile keratitis (or infiltrative keratitis; IK) is a term used to define non-progressive 
keratitis as its cause is not directly related to a microbial infection.94,97 If microbes are present in 
sterile infiltrates, its active growth is usually halted.93 It is important for clinicians to be able to 
identify the difference between the two types of infiltrates, as infectious infiltrates require 
immediate medical attention. They are often distinguished from each other through location, size, 
shape and colour.93 Infectious infiltrates are characterized to have diameters larger than 2.0 mm, 
and are normally located close to the center of the cornea with more widely spread out borders.93 
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Sterile infiltrates, however, are less than 1.0 mm in diameter and are typically located on the outer 
ends of the cornea, and have more precise edges.93  
 
Corneal infiltrates associated with contact lens wear have been the subject of many reports 
in the literature. Common forms include contact lens-induced peripheral ulcer (CLPU) and contact 
lens-associated red eye (CLARE).93 Research has shown that lens modality can be a factor in 
developing both microbial or sterile keratitis.93 For instance, the risk of developing microbial 
keratitis and sterile keratitis in extended-wear soft lens was reported to be 36.8 and 4.6 times higher 
than in RGP lens wearers respectively.93,98 Similarly, there was a higher risk of developing 
microbial and sterile keratitis in daily–wear soft contact lens wearers (4.2 and 2.3 times, 
respectively) when compared to RGP lenses.93,98  
 
Structural and physiological changes to the cornea caused by contact lens wear can 
eventually lead to the development of CIEs.93 Contact lens-associated CIEs can be induced in a 
variety of ways. For example, when the corneal epithelial cells are damaged due to hypoxia and 
corneal trauma caused by lens wear, they often release proinflammatory cytokines, thus inducing 
an inflammatory response.93,99 In other cases, the lenses can act as a hub for bacteria or debris 
which when transferred to the cornea or held against the corneal surface, can lead to the 
development of CIEs.93 In some cases, the contact lens material itself or the deposits present on 
the lens materials can act as proinflammatory agents and stimulate a proinflammatory response, 
thus leading to CIEs.93 Evidently, when the corneal epithelium is subject to any form of 
mechanical, hypoxic, or toxic condition, they signal for the stromal keratocytes to produce 
proinflammatory cytokines as an immune response.93 These cytokines and chemokines, such as 
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IL-8, in return signal for the infiltration of inflammatory cells to the corneal surface, whose 
aggregation ultimately lead to CIEs.93  
 
1.4.4.1 Contact Lens Induced Inflammation 
 
The relationship between contact lens wear, ocular inflammation and contact lens 
discomfort has been investigated in several studies. Ocular inflammation is commonly analyzed 
by quantifying the inflammatory mediators present during contact lens wear. In 2016, Efron 
proposed the idea that asymptomatic contact lens wear is intrinsically inflammatory.100  In his 
article he explained that symptoms from uncomplicated lens wear meet the criteria for both clinical 
and subclinical definitions of inflammation. The criteria for clinical inflammation included: 
redness, heat, swelling, pain, and loss of function.100 The criteria for sub-clinical inflammation 
included cellular and biochemical reactions.100 While hydrogel lens wear presented with all signs 
for both forms of inflammation, silicone hydrogel presented most forms.100 One notable sign of 
inflammation that was present in both hydrogel and silicone hydrogel lens wear was the presence 
of biochemical reactions, specifically the up-regulation of inflammatory mediators.100 
 
There have been several studies conducted which investigated the relationship between 
contact lens wear and the presence of inflammatory mediators. The purpose of these studies was 
to further understand ocular inflammation as a response to contact lens wear.   
 
In a study conducted by Poyraz et al., the researchers focused on quantifying the 
concentrations of IL-6 and IL-8 in neophyte contact lens wearers.101 Recruited participants were 
either fitted to silicone hydrogel lens or conventional hydrogel lens and were asked to wear the 
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lens for a 6 month period for 8 hours a day.101 Tear samples were collected from the participants 
at the 0, 1, 3- and 6-month time mark. Cytokine concentrations of IL-6 and IL-8 from the tear 
samples were then analyzed using an ELISA.101 Tear levels of IL-6 and IL-8 from both lens wear 
groups were found to have significantly increased at 6 months when compared to the levels 
reported at the 0 and 1 months marks (p < 0.001).101 The researchers concluded that both silicone 
hydrogel and hydrogel contact lens wear caused an ocular inflammatory response, specifically an 
increase in IL-6 and IL-8 in neophyte contact lens wearers over a 6-month period.101 In another 
study, Dogru et al., recruited participants and fitted them with senofilcon A silicone hydrogel 
lenses.102  Participants were asked to wear the lenses for a 2-week period for 12 hours a day. Tear 
samples were collected pre-lens wear and post-lens wear.102 They found that tear IL-6 levels were 
significantly increased after the 12-week period (post-wear mean: 2505 ± 951 pg/mL; pre-wear 
mean: 1516 ± 497 pg/mL).102  The results from this study further support the idea that contact lens 
wear can induce an increase in cytokine concentration in the eye.    
 
González-Pérez et al. conducted a study focused on determining whether continuous wear 
of silicone hydrogel lenses and reverse geometry rigid contact lenses influenced tear film 
inflammatory mediator concentrations.103 Reverse geometry contact lenses have been used in 
corneal refractive therapy to induce short-term flattening of the corneal curvature to reduce or slow 
the progression of myopic refractive error.103,104 While these treatments do have their advantages, 
researchers were interested in noting whether the cornea was compromised by inflammation and 
infections during the corneal flattening treatments.103 They were interested in analyzing the tear 
marker concentrations to determine whether there were inflammatory events that occurred after 
extended wear of silicone hydrogel lens and overnight corneal refractive therapy.103 The tear 
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markers of interest were: IL-6, IL-8, epidermal growth factor (EGF), and MMP-9. Results from 
their study showed that after 12 months of continuous lens wear, there was an increase in tear 
levels of IL-6, IL-8, MMP-9, and EGF in the overnight corneal refractive therapy group in 
comparison to the silicone hydrogel lens wear group as well as the no lens wear control group.103 
From these results it was understood that the upregulation of these inflammatory markers was a 
response to the changes that were occurring on the corneal surface.103 While the inflammatory 
response could be a mechanism used to assist with corneal wound healing as well as corneal 
protection, it is unknown if these inflammatory responses have any long term negative impacts.103  
 
 Acanthamoeba Keratitis (AK) is an ocular infection caused by the amoebae Acanthamoeba 
that can possibly lead to vision loss.105 It has been reported that contact lens wear is the leading 
cause of AK,105 particularly when associated with the exposure of the lenses to tap water. Common 
symptoms experienced by affected people include pain, tearing, photophobia, and infiltrates in the 
stroma.105 In a study conducted by Carnt et al., they wanted to compare tear cytokine levels 
between contact lens wearers that had AK and lens wearers without the disease.106 They also 
wanted to compare cytokine levels in patients with severe forms of AK disease with those that had 
a milder form of the disease.106 Of the various cytokines analyzed, IL-8 was found to be detected 
more in tear samples collected from patients with AK in comparison to tear samples from non-AK 
patients (p = 0.003).106 In addition, higher concentrations were found in tear samples from patients 
who had a more severe form of AK compared to those that had a milder form. Aside from IL-8, 
IL-22 was also detected more frequently in severe forms of AK than milder forms.106 Results from 
all these studies further support the idea that contact lens-induced diseases can impact the ocular 
environment and thus eventually lead to an inflammatory response. 
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1.4.4.2  Silicone hydrogel contact lens and CIEs 
 
 The development of silicone hydrogel contact lens has its advantages. The presence of 
silicone in the contact lens material allowed for an increased permeability of oxygen through the 
lenses to the cornea. It was predicted that with an increase in oxygen permeability, there would be 
a decrease in the risk of developing hypoxic conditions.83 However, although risks with hypoxia-
related conditions have been reduced, the possibility of developing ocular inflammation and 
infection remains, as the lack of oxygen is not the only factor contributing to the development of 
microbial keratitis.107,108  In fact, reports have shown that the risk of developing CIEs from silicone 
hydrogel contact lens wear is two times higher than in the lower oxygen permeable contact lens.109-
111 In a meta-analysis conducted by Szczotka-Flynn and Diaz, they reported that there was a two-
fold higher risk in developing CIEs when wearing extended wear silicone hydrogel lenses for 30 
days in comparison to wearing lower oxygen permeable lenses for 7 days.107 Researchers were, 
however, unable to determine whether the increase in CIEs was primarily due to the difference in 
contact lens material as the length in wear time also had an impact on these results.107 Furthermore, 
reports have shown that planktonic bacterial cells adhere more to certain silicone hydrogel lenses 
in comparison to hydrogel lenses, which can also be a cause for the increase in CIE 
development.109,112 In fact, in a study conducted to determine the risk factors associated with CIEs 
in young soft contact lens wearers, they found that the age of patient, lens care products, years of 
lens wearing experience, soft contact lens material, and extended wear were all contributing 
factors.113 Now, while all these factors have been reported to influence contact lens associated 




1.4.5 Protein Deposition Profiles  
A lot of research has gone into determining how the materials used in contact lens impacts 
the development of CIEs. Contact lenses have been reported to be deposited with various proteins, 
lipids and calcium.94 When these proteins or lipids denature, the ocular immune system may 
recognize them as foreign bodies. The immune response will then lead to the upregulation of 
inflammatory markers eventually causing PMNs to infiltrate into the ocular tissue.94 
 
 Protein deposition and lipid deposition onto both hydrogel and silicone hydrogel lenses 
have been discussed in the literature. Properties of the contact lens, such as its hydrophobic or 
hydrophilic character and the monomer’s ionic charge, influence protein deposition profiles on 
various lens materials. The protein’s properties such as its size and isoelectric point also influence 
protein deposition profiles.59 For example, the total amount of protein deposited onto worn Group 
I, II, III lenses has been found to be less than 100 µg, whereas, 400 µg to 2000 µg of protein have 
been found to be deposited onto most Group IV lenses.59 Lysozyme deposition also varies between 
lens types, as twice the percentage of active lysozyme has been found to be on ionic materials in 
comparison to non-ionic materials.59  
 
 While the deposition of various proteins such as lysozyme, lactoferrin, and albumin have 
all been discussed in the literature, there is minimal information with regards to cytokine 
deposition on contact lens. In 2019, Chao et al., conducted an experiment to determine the levels 
of cytokines absorbed, or firmly bound by lens materials.114 The lenses that were investigated in 
this study were: comfilcon A, balafilcon A, omafilcon A, and etafilcon A. These lenses were 
soaked into both individual and combined protein solutions of IL-8, MMP-9 or IL-1Ra at 
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concentrations of either 500 pg/mL or 100 pg/mL.114  The inflammatory markers of interest were 
then extracted from the lenses using a 1:1 2% trifluoroacetic acid: acetonitrile. The results from 
this study showed that in a solution of MMP-9 (500 pg/mL), omafilcon A (466 ± 9 pg/mL) 
absorbed more MMP-9 in comparison to balafilcon A (437 ± 11 pg/mL) and etafilcon A ( 428 ± 
13 pg/mL).114 There was more MMP-9 firmly bound to omafilcon A, comofilcon A and balafilcon 
A in comparison to etafilcon A lenses.114 With respect to IL-8, they found no differences in 
absorptions between the lenses, however at 500 pg/mL, more IL-8 was found to be firmly bound 
to omafilcon A than etafilcon A.114 It was also reported that there was no difference between the 
materials with regards to both absorbed and firmly bound concentrations of IL-1Ra.114 When lenses 
were placed into a solution that combined all the analytes of interest, it was found that etafilcon A 
lenses absorbed more IL-8 in comparison to the other lens materials.114 This study concluded that 
competitive binding between the various mediators played a role in absorption and extraction by 
the lens materials.114  
 
 With minimal information regarding cytokines deposition onto contact lens materials, there 
is a growing interest in determining whether cytokines bound to contact lens materials play a role 
in inducing CIEs. The research undertaken in this thesis focuses cytokines released from contact 
lens materials.  
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Chapter 2: Thesis Rationale 
2.1 Objectives 
The effect of contact lens wear on inflammatory biomarkers in the tear film has been fairly 
well documented. With lens wear, there is a risk for corneal infection and inflammation.97,115,116  
Research shows that lens wear can influence tear concentration levels of inflammatory 
markers.101,117-120 The amount of inflammatory markers present during pre- and post-lens wear is 
often quantified by collecting tear samples from lens wearers and analyzing them with antibody-
based assays. While such a process provides insight into the relationship between ocular 
inflammation and contact lens wear, it does not account for the interaction between the markers of 
interest and lens materials. There has been little discussion regarding the adsorption, deposition, 
and release of cytokines onto contact lens materials. Studying the interaction between cytokines 
and lens materials may help understand the mechanisms causing contact lens discomfort, ocular 
inflammation, and CIEs.  In particular, the question of why there is a 2X greater risk of developing 
CIEs with silicone hydrogel lens wear can be answered.107    
 
 There were three main objectives in this thesis. The first objective was to develop a protocol 
that would aid in quantifying the amount of adhered cytokines released from contact lens materials.  
The second was to determine whether the release of cytokines differed between contact lens 
materials that were pre-exposed to various ocular conditions.  The third objective was to determine 
whether the release of cytokines differed between protein-coated (lysozyme, lactoferrin, or 
albumin) contact lens materials.  
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2.2 Contact Lens of Interest 
It was important to investigate both conventional and silicone hydrogel lenses because, 
while protein deposition occurs on both, their deposition profiles vary greatly. Charge, water 
content, and surface properties of the lens material influence the extent of deposition.  Absorption 
typically increases with increased water content and favourable electrostatic attractions.121  To 
understand how the release of cytokines differs between materials, four different daily disposable 
lens types were used.  The hydrogel contact lenses of interest in this thesis were: etafilcon A (1-
Day Acuvue® Moist®) (ionic, high water content) and omafilcon A (Proclear® 1 day) (non-ionic, 
high water content). The silicone hydrogel lens of interest were: somofilcon A (Clariti ™1 day) 
(non-ionic, high water content) and delefilcon A (Dailies Total1®) (core material – non-ionic, low 
water content; surface coating: non-ionic, high water content). Table 2.2-a illustrates some of the 
main properties of these lens materials. 
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Table 2.2-a: Properties of Contact Lens Materials Investigated in This Thesis 
 United States Adopted Name (USAN) 
 Etafilcon A Omafilcon A Somofilcon A Delefilcon A 
Proprietary name 1-Day Acuvue® 
Moist® 
Proclear® 1 day Clariti ™1 day Dailies Total1® 
FDA category IV II V V 
Ionicity Ionic Non-ionic Non-ionic Non-ionic 
Modality Daily Disposable Daily Disposable Daily Disposable Daily Disposable 
Water Content (%) 58 122,123 60122 56123 Gradient: 
33 (core), ³ 80 
(surface)122,123 
Dk/t @ -3.00D 25.5 28.0 86.0 156.0 
Principle Monomer HEMA + MA81 HEMA + PC81 Alkyl methacrylates, 
siloxane monomers, 
NVP123 
The core: DMA, TRIS-
Am, siloxane macromer 




HEMA = 2-hydroxyethyl methacrylate; MA = methacrylic acid; DMA = N,M-dimethylacrylamide; NVP = N-vinyl pyrrolidone; PC = 
2-methacryloylethyl phosphorylcholine; TRIS-Am = N-[trismethylsiloxy)-silylpropyl]acrylamide. 
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2.3 Cytokines of Interest 
Inflammatory responses, both pro-inflammatory and anti-inflammatory responses, are 
promoted through cytokine activity.40,41 Human tears have been analyzed for the presence and 
basal levels of cytokines and chemokines. Of the 30 cytokines analyzed, 25 were detected.55  Due 
to their prominent roles in the inflammatory cascade, this thesis chose to focus on four cytokines: 
IL-1β, IL-6, IL-8, and TNF-⍺. When it comes to initiating an inflammatory response, there is a 
cytokine hierarchy. In a study that looked at the hierarchy of IL-1β, IL-6, IL-17A, and TNF, it was 
found that IL-1β required the least amount of expression to cause an inflammatory response in the 
eye.124 An experimental study showed that small increments of IL-1β levels in the eye can 
contribute to the development of ocular inflammation over time.124 IL-1β, a proinflammatory 
cytokine, is secreted by monocytes, macrophages, dendritic cells, and neutrophils.125 While IL-1β 
has a crucial role in initiating inflammatory responses, it can also impose toxic effects inside the 
human body. Hence, its production is highly regulated.126  Apart from being involved in infection 
control and cellular activity, IL-1β can also regulate the secretion of other cytokines such as IL-6, 
IL-8, and TNF-⍺.49,127  While TNF can also initiate ocular inflammation, in comparison to IL-1β, 
increased amounts of expression is required.124 TNF-⍺ is involved in the development of 
inflammatory, neovascular, and neurodegenerative ocular conditions.128 IL-6 is a cytokine that can 
be both anti-inflammatory and pro-inflammatory. Although it can protect the eye against infection, 
it can also cause damage to ocular tissues via neovascularization or increasing the severity of 
inflammation.51  Higher levels of IL-6 have been detected in those with a history of CIEs in 
comparison to tears from healthy participants.119 IL-8 is a highly regulated pro-inflammatory 
chemokine.52 It is expressed at the early stages of inflammation and can sustain its active state for 
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time periods as long as weeks.52 As a chemokine, it signals for the migration of neutrophils, 
basophils and T lymphocytes to sites of inflammation.52   
 
Neophyte silicone and conventional hydrogel lens wearers have been found to have 
increased IL-6 and IL-8 levels after a six month wear period.101 Due to their presence in ocular 
inflammation and tears from contact lens wearers, it was thus of interest to study the release of IL-
1β, IL-6, IL-8, and TNF-⍺ from contact lens materials. Properties pertaining to the cytokines 
studied as well as basal levels found in human tears are illustrated in Table 2.3-a.  
 
Table 2.3-a. Properties and Basal Levels in Tears of Cytokines Studied in this Thesis 








Cytokine  Molecular 
Weight 
pI point Basal levels in tears 
(mean ± SD) (pg/mL) 
IL-1β 17 kDa 44* 
 
~ 5.8 * 58.32 ± 3.61129, 9.6 ± 7.9130, 436.3 ± 
116.747, 12.9 ± 2.354, 13.0 ± 4.0131, 
7.42±5.62132 
IL-6 21-28 kDa51, 
20.3 kDa* 
~ 6* 2634.49 ± 251.99129, 89.5 ± 83.5130,  
632.3 ± 167.947,  
226.2 ± 29.654, 171.8±32.1131, 
13.43±8.74132 
 
IL-8 8-10 kDa52, 
8 kDa* 
~ 8.5* 729.11 ± 46.26129, 16791.4 ± 2841.247, 
731.4 ± 47.554, 56.5±33.8131 
 
TNF-⍺ 17 kDa50 
17.5 kDa* 
~ 6.9* 252.6 ± 275.3130 , 250.6  ±  63.247,  




In this thesis, in vitro studies were set out to investigate the release of adhered cytokines 
from daily disposable contact lens materials. It is hypothesized that silicone hydrogel lens releases 
more cytokines than conventional hydrogel lens materials. It is predicted that these cytokines then 
re-enter the ocular environment and stimulate an inflammatory response, leading to the 










Chapter 3: Protocol Development 
3.1 Introduction 
While the deposition of proteins, such as lysozyme, onto contact lenses has been 
investigated in the literature, minimal research with regards to the deposition of cytokines onto 
contact lenses has been conducted. In 2019, Chao and colleagues investigated whether 
inflammatory markers were absorbed or bound to contact lens materials.  In the study, a 1:1 ratio 
of 2% trifluoroacetic acid and acetonitrile solution was used to extract cytokines from contact 
lenses to determine the concentration of absorbed and firmly bound cytokines.114  While this study 
focused on studying proteins absorbed to contact lens materials, an earlier study conducted in 2007 
by Mann and Tighe focused on analyzing the proteins present in the “tear envelope”.133 This 
concept refers to a small layer of the tear film which encloses the contact lens the moment it is 
removed from the lens wearer’s eye. The purpose of analyzing the tear envelope was to investigate 
the relationship between tear film composition and the contact lens surface.133 In this study, 
participant-worn lenses were collected, placed into 0.5 mL microcentrifuge tubes and immersed 
in 5μL of a buffer solution if the lenses were found to be dry.133 The tube was vortexed and 
subsequently, a small hole was created at its base. The 0.5 mL lens-containing tube was then placed 
into a 1.5 mL microtube. Together, they were centrifuged at 3000 r.p.m. for a total of 15 minutes. 
The eluate collected in the 1.5mL tube was immediately analyzed for proteins on the 2100 
Bioanalyzer using the Protein 200 Plus LabChip kits.133  A similar protocol was used in another 
study to also analyze proteins in the tear envelope.134 However, in this study, the contact lens was 
submerged into 40μL of sodium dodecyl sulphate (SDS) and 2-mercaptoethanol.134 The lens-
containing tube and the carrier tube it was placed in underwent ultracentrifugation at 5000 r.p,m 
for 10 minutes. The eluate collected in the larger tube was then processed using SDS-PAGE.134   
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 These methods were used to analyze the tear film enclosing worn contact lenses. For the 
studies conducted in this thesis, the main purpose was to quantify the amount of adhered cytokines 
released by contact lens materials through an in vitro model. Thus, the protocol mentioned in the 
study conducted by Mann and Tighe133 was adapted to explore the effects of changing various 
variables, to then finalize a protocol that would provide ideal results for future studies. All the 
studies conducted in this thesis were done in vitro.  
 
The results from the studies conducted below, provided parameters that assisted in 
developing a protocol that was suitable for quantifying the amount of adhered cytokines released 
by contact lens materials. 
 
To develop the protocol, the effects of changing three variables were explored: 
temperature, incubation period, and volume of diluent. Prior to conducting the experiments, it was 
decided that all studies would be conducted using Diluent 2. Diluent 2, as described by the MSD 
Scientific Support Group, is a proprietary phosphate-buffered solution (PBS) with a pH of ~ 7.4. 
It is provided as the assay diluent in the MSD Proinflammatory Panel II (human) Kit which is an 
immunoassay kit used to quantify cytokines, specifically: IL-1β, IL-6, IL-8 and TNF-⍺. The 
Diluent 2 provided, is specifically used to reconstitute the lyophilized calibrator blend, which 
contains IL-1β, IL-6, IL-8 and TNF-⍺, to prepare the cytokine solution. Thus, by using the same 
solution, it helps to minimize any effects that may be due to the interaction between the solvent 






Experiment 1: Temperature  
 
 In this study, contact lenses were soaked in a cytokine solution. Following the soaking 
period, they were immediately placed into a Diluent 2 solution. It was of interest to determine 
whether incubating the contact lens in Diluent 2 at different temperatures (room temperature and 
body temperature of 37℃) impacted the amount of cytokines released by the lens materials. In a 
study conducted by Kessel et al., it was found that human corneal temperatures can range between 
36.5℃ to 37 ℃ when the ambient temperature is increased.135  As contact lenses sit on the ocular 
surface, whether or not ocular temperature influences the adhered cytokines from coming off the 
lens surface and back into the tear film was worthy of determination. Thus, for this experiment, 
the temperatures chosen were the maximum ocular temperature, 37℃, and room temperature. 
 
Experiment 2: Incubation Period 
 
 Once the temperature was decided, the next variable explored was the incubation period. 
The incubation periods of choice were 0 hours or 1 hour. In the case of zero-hours (no incubation), 
contact lenses were removed from the cytokine solution post soak period and then immediately 
placed into the Diluent 2 solution to then be vortexed. However, in the case of a one-hour 
incubation period, once the lenses were removed from the cytokine solution, they were left to 
incubate in a Diluent 2 solution for 1 hour before being vortexed. The objective was to determine 
whether increasing the incubation period increased the amount of adhered cytokines released from 







Experiment 3: The volume of Diluent 2 required  
 
 The final variable that was analyzed was the volume of Diluent 2 required to aid in the 
removal of adhered cytokines. There were two volumes tested in this experiment: 200 μL and 550 
μL. With a volume of 200 μL, the contact lens material was submerged inside the diluent. With 
the volume of 550 μL, diluent 2 filled the 0.6mL tube entirely. This experiment helped determine 
whether increasing the diluent volume would increase the amount of cytokines removed from the 
contact lenses.   
   
3.2 Temperature Study  
3.2.1 Materials and Methods 
 
Contact Lenses of Interest and Cytokine Solution 
 
 A total of four different contact lens materials (n = 3 for each lens material in each 
condition), were investigated in this study. This consisted of two conventional hydrogels (etafilcon 
A; omafilcon A) and two silicone hydrogels (delefilcon A; somofilcon A). A multi-analyte 
lyophilized calibrator (Meso Scale Diagnostics, Rockville, MD) containing the cytokines, IL-1β, 
IL-6, IL-8, and TNF-⍺, was reconstituted in 7mL of Meso Scale Discovery’s Diluent 2 to prepare 
a cytokine solution. The theoretical concentrations of IL-1β, IL-6, IL-8, and TNF-⍺ in the prepared 
cytokine solution were reported as 88.57 pg/mL, 112.71 pg/mL, 74.14 pg/mL and 45 pg/mL, 
respectively. 
 
Sample Preparation   
 
 Contact lenses were removed from their packaging solution and immediately rinsed in a 
PBS solution (Lonza Biosciences, Walkersville, MD). Excess PBS solution was removed on lens 
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paper (VWR, Radnor, PA). The lenses were individually placed into 5 mL conical-bottom 
polypropylene tubes (VWR, Radnor, PA) and soaked in 200 μL of the prepared cytokine solution. 
A control solution was prepared for each lens type in each condition. For this study, controls (n = 
1 for each lens material in each condition), were used where the lenses underwent the same 
procedure. However, the lenses were soaked in 200μL of Diluent 2 rather than a cytokine solution.  
The purpose of this was to quantify background data produced by the lens. The lenses were left to 
incubate at room temperature for 6 hours with shaking. Post the 6-hour incubation period, lenses 
were removed from the polypropylene tubes and immersed into 200 μL of Diluent 2 in a 0.6 mL 
microcentrifuge tube (AxygenÒ, Inc, Union City, CA).  The lenses were then placed on the Orbital 
Shaker (VWR, Radnor, PA) to incubate at either room temperature or on the INNOVA 4200 
incubator shaker (New Brunswick Scientific Company, Inc., Edison, NJ) at 37℃ for 1 hour with 
shaking. Subsequently, the tubes were vortexed for 5 seconds and pin-sized holes were made at its 
base. The 0.6 mL lens-containing tubes were then placed into a 2.0 mL microcentrifuge tube 
(AxygenÒ, Inc, Union City, CA) which acted as carrier tubes. Together, they were centrifuged 
using the MiniSpinÒ (Eppendorf, Mississauga, ON) at 604 relative centrifugal force (RCF) for 15 
minutes. Post centrifugation, eluate was collected in each 2.0 mL tube and stored at -80℃. 
Cytokine quantification was performed at a later date using a multiplex electrochemiluminescence 
(ECL) assay Human Proinflammatory Panel II (4-Plex) assay (Meso Scale Diagnostics, Rockville, 
MD) and the MESO QuickPlex SQ 120 Imager (Meso Scale Diagnostics, Rockville, MD).  A 









Data were analyzed using GraphPad Prism V8 software (GraphPad Software Inc., San 
Diego, CA).  A two-way ANOVA with Sidak’s multiple comparisons test was performed to 
determine whether there was a significant difference, within a single lens type, between the 
cytokines released by hydrogels at the two temperatures of interest. A two-way ANOVA with 
Tukey’s multiple comparisons test was performed to determine whether there was a significant 
difference between hydrogel materials concerning the amount of cytokines released. Results for 
both tests were considered significant if p < 0.05.  
 
3.2.2 Results 
 The amount of adhered cytokines released by each hydrogel is shown in Figure 3-2, Figure 
3-3, Figure 3-4, and Figure 3-5 and summarized in Table 3.2-a, Table 3.2-b, Table 3.2-c, and Table 
3.2-d (reported as mean ± standard deviation).  There was no significant difference within a single 
lens type, between temperatures, with respect to the amount of cytokines released for all four 
cytokines (adjusted p-value > 0.05).  In addition, there was no significant difference between the 
hydrogel materials concerning the amount of cytokines released (adjusted p-value > 0.05).   To 
calculate the amount of cytokines released by the lens materials in pg/lens the following 
calculation was made: 
Equation 3.2-1: Amount of adhered cytokines released by contact lens materials (pg/mL) 
 
This equation was used for all studies conducted in this thesis to calculate the amount of cytokines 
released by contact lens materials in pg/lens.  
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Table 3.2-a: IL-1β released by contact lens materials incubated at room temperature or 37℃ 
Lens type Room temperature, pg/lens 
 
37 ℃, pg/lens Adjusted p-value 
Etafilcon A 1.288 ± 1.248 0.787 ± 0.343 0.8168 
Omafilcon A 1.102 ± 0.305 1.053 ± 0.535 > 0.9999 
Somofilcon A 1.327 ± 0.441 1.129 ± 0.335 0.9926 
Delefilcon A 1.693 ± 0.888 1.763 ± 0.183 0.9999 
Table 3.2-b: IL-6 released by contact lens materials incubated at room temperature or 37℃ 
Lens Type Room temperature, pg/ lens 
 
37 ℃, pg/lens Adjusted p-value 
Etafilcon A 1.837 ± 1.697 1.258 ± 0.565 0.8659 
Omafilcon A 1.524 ± 0.402 1.522 ± 0.654 > 0.9999 
Somofilcon A 2.055 ± 0.663 1.690 ± 0.532 0.9714 
Delefilcon A 2.122 ± 0.845 2.208 ± 0.208 0.9999 
 
 
Table 3.2-c: IL-8 released by contact lens materials incubated at room temperature or 37℃ 
Lens Type Room temperature, pg/ lens 
 
37 ℃, pg/lens Adjusted p-value 
Etafilcon A 1.070 ± 0.996 0.718 ± 0.324 0.8605 
Omafilcon A 1.028 ± 0.237 0.928 ± 0.479 0.9986 
Somofilcon A 1.233 ± 0.324 1.020 ± 0.286 0.9740 
Delefilcon A 1.355 ± 0.525 1.428 ± 0.210 0.9996 
 
Table 3.2-d: TNF-⍺ released by contact lens materials incubated at room temperature or 37℃ 
Lens Type Room temperature, pg/ lens 
 
37 ℃, pg/lens Adjusted p-value 
Etafilcon A 0.562 ± 0.534 0.365 ± 0.173 0.8507 
Omafilcon A 0.470 ± 0.097 0.501 ± 0.205 0.9999 
Somofilcon A 0.649 ± 0.212 0.483 ± 0.134 0.9125 





































































































































































The purpose of the experiments conducted in this chapter was to develop a protocol that 
would aid in quantifying the amount of adhered cytokines released by contact lens materials. 
Protocol development involved analyzing the effects of three variables individually. Based on the 
results of each study, a final protocol that was best appropriate to study the cytokines of interest 
was chosen.   
 
In this study, two temperature settings, room temperature and 37℃, were explored to 
determine which condition would provide a protocol that would result in a release of more adhered 
cytokines from the lens materials. According to the results shown in section 3.2.2, there was no 
statistically significant difference between the results obtained for either temperature (adjusted p-
value > 0.05).  Also, there was no significant difference found between materials at each 
temperature (adjusted p-value > 0.05).  
 
As the results show, increasing the temperature to the maximum ocular temperature did 
not result in an increase or decrease in the release of cytokines from the lens materials. Multiple 
factors influence the adherence of protein molecules to lens materials. In this study, there were 
four contact lens materials (etafilcon A, somofilcon A, delefilcon A and omafilcon A) and four 
cytokines (IL-1β, IL-6, IL-8, and TNF-⍺) of interest. It was interesting to find that the conventional 
hydrogels, etafilcon A and omafilcon A, behaved similarly to the silicone hydrogels delefilcon A 
and somofilcon A.   
 
It has been reported in the literature that surface charges of both the protein molecules and 
lens materials can influence their interaction.136  Etafilcon A is a negatively charged lens material. 
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Its ionic character is due to the copolymerization of the negatively charged methacrylic acid (MA) 
monomer with HEMA.136 Due to its negative charge, theoretically, it should have a strong 
electrostatic attraction with positively charged protein molecules. From the cytokines of interest, 
IL-1β, IL-6, and TNF-⍺ were expected to be negatively charged in the calibrator solution, as their 
pI points (~5.8, ~6, ~6.9 respectively, as per MSD Scientific Support) are all below the pH of the 
diluent 2 (7.4, as per MSD Scientific Support) solution and IL-8 was expected to be positively 
charged as its pI point (~8.5, as per MSD Scientific Support) is above the pH of the diluent 2 
solution.  It was expected that the etafilcon A lens should have released more IL-1β, IL-6, and 
TNF-⍺ and less IL-8.  Omafilcon A, somofilcon A, and delefilcon A are non-ionic hydrogels and 
thus, there would be minimal electrostatic attraction present between the surface of the material 
and the cytokines. Due to these differences, it was expected that etafilcon A would release less IL-
8 in comparison to the other lens materials, however, no difference was found between the 
materials at either temperature (adjusted p-value > 0.05).  
 
Increasing the temperature can also weaken electrostatic attractions. With the use of an 
incubation temperature of 37℃, it was thought that there would be an increase in the release of 
cytokines from the lens materials due to a weaker interaction between the surface of the cytokines 
and the surface of the lens. However, there was no difference in the results with respect to the 
release of cytokines at either temperature (adjusted p-value > 0.05).    
 
While there was no significant difference between the temperatures for each lens material 
for all four cytokines, it was necessary to decide on temperature for subsequent studies. Although 
the results in these experiments did not show any difference, there is a possibility of protein 
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denaturation at higher temperatures. For future studies, it was important to have minimal 
interference in the results. Thus, to reduce the possibility of being unable to quantify cytokines due 
to its structure being denatured, it was decided that an incubation temperature of room temperature 
would be used for subsequent studies.  
 
3.3 Incubation Period Study 
3.3.1 Materials and Methods 
 
Contact Lens of Interest, Cytokine Solution, and Sample Preparation  
 
The contact lens of interest as well as the methods to prepare the cytokine solution are the 
same as those reported in section 3.2.1. The theoretical concentrations of IL-1β, IL-6, IL-8, and 
TNF-⍺ in the prepared cytokine solution is reported to be 88.57 pg/mL, 112.71 pg/mL, 74.14 
pg/mL and 45 pg/mL respectively. The methodology used to prepare samples for this experiment 
was similar to that of section 3.2.1. The change made in this experiment was that for the second 
incubation period, the 0.6 mL lens-containing microtubes were left to incubate at room temperature 
in 200 μL in one of two conditions, 0 hours (no incubation period) or 1 hour. All other steps 




Data were analyzed using GraphPad Prism V8 software (GraphPad Software Inc., San 
Diego, CA).  A two-way ANOVA with Sidak’s multiple comparisons test was performed to 
determine whether there was a significant difference, within a single lens type, between the 
cytokines released by hydrogels at the two incubation periods of interest. A two-way ANOVA 
with Tukey’s multiple comparisons test was performed to determine whether there was a 
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significant difference between hydrogel materials with respect to the amount of cytokines released. 
Amount of cytokines released was calculated using Equation 3.2-1. Results for both tests were 
considered significant if p < 0.05.  
 





 The amount of adhered cytokines released by each hydrogel is shown in and summarized 
in Table 3.3-a, Table 3.3-b, Table 3.3-c, and Table 3.3-d (reported as mean ± standard deviation) 
and illustrated in Figure 3-7, Figure 3-8, Figure 3-9, and Figure 3-10. There was no significant 
difference between incubation periods with respect to the amount of cytokines released by each 
hydrogel for all four cytokines (adjusted p-value > 0.05).  In addition, there was no significant 
difference between the hydrogel materials with respect to the amount of cytokines released 
(adjusted p-value > 0.05).   
Table 3.3-a: Il-1β released by contact lens materials incubated for 0 hours or 1 hour 
Lens Type 0 hour, pg/lens 
 
1 hour pg/lens Adjusted p-value 
Etafilcon A 0.578 ± 0.185 1.135 ± 0.718 0.5831 
Omafilcon A 0.873 ± 0.797 0.560 ± 0.623 0.9152 
Somofilcon A 0.548 ± 0.307 0.599 ± 0.271 > 0.999 
Delefilcon A 1.131 ± 0.461 1.039 ± 0.307 0.9991 
 
Table 3.3-b: Il-6 released by contact lens materials incubated for 0 hours or 1 hour 
Lens type 0 hour, pg/lens 
 
1 hour pg/lens Adjusted p-value 
Etafilcon A 0.852 ± 0.217 1.389 ± 0.902 0.8195 
Omafilcon A 1.091 ± 1.189 0.727 ± 0.758 0.9476 
Somofilcon A 0.812 ± 0.443 0.973 ± 0.451 0.9975 
Delefilcon A 1.467 ± 0.569 1.340 ± 0.349 0.9990 
 
Table 3.3-c: IL-8 released by contact lens materials incubated for 0 hours or 1 hour 
Lens type 0 hour, pg/lens 
 
1 hour pg/lens Adjusted p-value 
Etafilcon A 0.585 ± 0.150 1.057 ± 0.598 0.7819 
Omafilcon A 0.756 ± 0.689 0.442 ± 0.453 0.9383 
Somofilcon A 0.550 ± 0.165 1.074 ± 1.110 0.7129 





Table 3.3-d: TNF-⍺ released by contact lens materials incubated for 0 hours or 1 hour 
Lens Type 0 hour, pg/lens 
 
1 hour pg/lens Adjusted p-value 
Etafilcon A 0.275 ± 0.078 0.485 ± 0.361 0.7311 
Omafilcon A 0.374 ± 0.335 0.252 ± 0.274 0.9495 
Somofilcon A 0.230 ± 0.105 0.297 ± 0.138 0.9942 



















































































































Figure 3-10: Amounts of TNF-⍺ released by contact lens materials incubated for 0 hours or 1 hour. 
 
 
3.3.3 Discussion  
The purpose of this investigation was to determine whether increasing the incubation 
period would result in an increase or decrease of adhered cytokines released from the contact lens 
materials. The two incubation periods tested were 0 hours and 1 hour.  As results show in section 
3.3.2, there was no statistically significant difference between the results obtained for either 
incubation periods. There was also no significant difference between lens materials.   
 
 As mentioned previously, various factors can influence the binding of cytokines to lens 
materials. It has been reported in the literature that competitive adsorption of proteins onto the 
surface may exist due to the Vroman effect.114,137 This phenomenon refers to the displacement of 
proteins adsorbed to a surface by various other proteins which may have a higher affinity for the 


































place over time. Due to factors such as molecular weight, certain proteins are less mobile than 
others and thus will not bind to the surface of the material as rapidly as the more mobile proteins. 
However, over time, proteins with a higher affinity for the surface will begin to displace proteins 
with lower affinity.114,137 The loosely bound proteins will then be released back into the solution.114   
 
 In this study, it was interesting to see whether increasing the incubation period would 
possibly allow for the Vroman effect to take place and thus have an effect on cytokines released 
from the materials. For example, Il-8 is a positively charged cytokine in Diluent 2. Thus, it would 
have a greater affinity for the negatively charged etafilcon A material in comparison to the other 
cytokines. With time, the IL-8 may displace the negatively charged cytokines, resulting in fewer 
amounts of IL-8 being released from the lens material. However, such a difference was not seen. 
A longer incubation period or a higher concentration of cytokines may be required for such an 
effect to take place. Nonetheless, in this study, there was no significant difference seen between 
the incubation periods. 
 
To conduct the subsequent experiments, it was necessary to decide on an incubation period.  
An incubation period of one hour was chosen. A decision was made to use the one-hour incubation 
period to allow for any loosely adhered cytokines to be released from the contact lens materials.  
 
3.4 Volume Study 
3.4.1 Materials and Methods 
Contact lens of interest, Cytokine Solution, Sample Preparation and Statistical Analysis  
 
The contact lens of interest as well as the methods to prepare the cytokine solution are the 
same as those reported in section 3.2.1. The theoretical concentrations of IL-1β, IL-6, IL-8, and 
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TNF-⍺ in the prepared cytokine solution were reported as 67.29 pg/mL, 91.57 pg/mL, 71.43 pg/mL 
and 45.29 pg/mL respectively. The methodology used to prepare samples for this experiment was 
similar to that of section 3.2.1. The change that was made in this experiment is that for the second 
incubation period, the 0.6 mL lens-containing microtubes were left to incubate at room temperature 
for 1 hour in one of two volumes of diluent 2, 200μL or 550 μL. In addition, for tubes with 550µL, 
the centrifugation step was repeated twice. This was due to the larger diluent 2 volume, as one 
centrifugation cycle was not sufficient to collect the full 550μL in the 2.0mL tube. A visual 
representation of the experiment is shown in Figure 3-11. Data were analyzed using GraphPad 
Prism V8 software (GraphPad Software Inc., San Diego, CA).  A two-way ANOVA with Sidak’s 
multiple comparisons test was performed to determine whether there was a significant difference, 
within a single lens type, between the cytokines released by hydrogels at the two Diluent 2 volumes 
of interest. A two-way ANOVA with Tukey’s multiple comparisons test was performed to 
determine whether there was a significant difference between hydrogel materials concerning the 
amount of cytokines released. Amount of cytokines released was calculated using Equation 3.2-1.  










The amount of adhered cytokines released by each hydrogel is shown in Figure 3-12, Figure 
3-13, Figure 3-14, and Figure 3-15 and is summarized in Table 3.4-a, Table 3.4-b, Table 3.4-c and 
Table 3.4-d (reported as mean ± standard deviation).  There was no significant difference between 
volumes with respect to the amount of cytokines released by each hydrogel for all four cytokines 
(adjusted p-value > 0.05).  When comparing the release of cytokines between contact lens 
materials, there was a significant increase of IL-6 released by etafilcon A in comparison to 
somofilcon A (p = 0.0473) and omafilcon A (p = 0.0438) when a diluent volume of 550 μL was 
used.  
Table 3.4-a: IL-1β released by contact lens materials incubated in 200μL or 500 μL of Diluent 2. 
Lens Type 200 μL, pg/lens 
 
550 μL, pg/lens 
 
Adjusted p-value 
Etafilcon A 0.910 ± 0.404 0.966 ± 0.626 0.9998 
Omafilcon A 0.608 ± 0.212 0.406 ± 0.185 0.9738 
Somofilcon A 0.361 ± 0.061 0.191 ± 0.108 0.9863 
Delefilcon A 0.671 ± 0.319 1.042 ± 0.972 0.8092 
 
Table 3.4-b: IL-6 released by contact lens materials incubated in 200μL or 500 μL of Diluent 2. 
Lens Type 200 μL, pg/lens 
 
550 μL, pg/lens 
 
Adjusted p-value 
Etafilcon A 1.160 ± 0.508 1.297 ± 0.722 0.9849 
Omafilcon A 0.196 ± 0.271 0.429 ± 0.110 0.3999 
Somofilcon A 0.622 ± 0.099 0.441 ± 0.172 0.9587 





Table 3.4-c: IL-8 released by contact lens materials incubated in 200μL or 500 μL of Diluent 2. 
Lens Type 200 μL, pg/lens 
 
550 μL, pg/lens 
 
Adjusted p-value 
Etafilcon A 0.892 ± 0.427 0.894 ± 0.499 >0.9999 
Omafilcon A 0.683 ± 0.203 0.309 ± 0.085 0.4181 
Somofilcon A 0.447 ± 0.085 0.343 ± 0.132 0.9865 
Delefilcon A 0.715 ± 0.365 0.469 ± 0.087 0.7688 
 
 
Table 3.4-d: TNF-⍺ released by contact lens materials incubated in 200μL or 500 μL of Diluent 2. 
Lens Type 200 μL, pg/lens 
 
550 μL, pg/lens 
 
Adjusted p-value 
Etafilcon A 0.534 ± 0.238 0.532 ± 0.349 > 0.9999 
Omafilcon A 0.402 ± 0.127 0.172 ± 0.054 0.4247 
Somofilcon A 0.285 ± 0.048 0.241 ± 0.080 0.9968 





Figure 3-12: Amounts of IL-1β released by contact lens materials incubated in 200μL or 500 μL of Diluent 
2. 
 
Figure 3-13: Amounts of IL-6 released by contact lens materials incubated in 200μL or 500 μL of Diluent 2. 
* A significant increase was seen with etafilcon A in comparison to somofilcon A and omofilcon A when the 




































































Figure 3-14: Amounts of IL-8 released by contact lens materials incubated in 200μL or 500 μL of Diluent 2. 
 





































































The purpose of this experiment was to determine whether increasing the volume of Diluent 
2 would result in an increase or decrease of adhered cytokines released from the contact lens 
materials. It was important to determine a suitable volume of diluent for this protocol because 
certain contact lens materials may require more or fewer volumes of extraction buffer depending 
on the amount of proteins they absorb.  For example, when extracting lysozyme from contact lens 
materials, the volume of extraction buffer (TFA/ACN) differs depending on the lens material. 
While silicone hydrogel materials require 1.5 mL, group IV lens materials, such as etafilcon A, 
requires 4 mL of the buffer solution.138  The volumes of Diluent 2 that were investigated in this 
study were 200μL and 500μL.  
 
As the results show in section 3.4.2, there was no statistically significant difference 
between the incubation periods for all four lens materials. This means that either of the volumes 
investigated of Diluent 2 could be used as a diluent to collect cytokines released from lens 
materials.  However, there was a significant difference between the amount of IL-6 released by 
etafilcon A compared to somofilcon A and omafilcon A when a diluent volume of 550 μL was 
used. A possible explanation for this is the difference in ionic properties between the lenses. While 
etafilcon A is a negatively charged material, omafilcon A and somofilcon A are non-ionic. In 
diluent 2, Il-6 is a negatively charged protein and thus it will have a repulsive electrostatic force 
with the surface of etafilcon A material in comparison to omafilcon A and somofilcon A.  For this 
reason, more IL-6 may have been released by etafilcon A. 
 
While there was no significant difference between the amount of cytokines released for 
either volume, it was necessary to decide on a volume of diluent 2 that would be best suitable for 
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the protocol. In this protocol, the subsequent step post-incubation period is to vortex the 
microcentrifuge tube. To reduce the possibility of losing cytokines to the sides of the tube during 
the vortex step, it was decided that a volume of 550μL would be best suitable for this protocol. A 
volume of 550μL fills the entirety of a 0.6mL microcentrifuge tube and thus reduces the possibility 
of having cytokines adhering to the sides of the microcentrifuge tube during the vortex step. 
 
3.5  Conclusion  
This concludes the experiments conducted to develop a protocol to quantify the amount of 
adhered cytokines released by contact lens materials. The final protocol involves incubating the 
cytokine adsorbed contact lenses in 550μL for 1 hour at room temperature. A visual representation 






Figure 3-16: A schematic diagram illustrating the finalized protocol. Created by Nijani. 
  
Place Contact Lens into 550μL of Diluent 2 
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Chapter 4: Investigating the Difference Between Treated Conventional and 
Silicone Hydrogel Lens and Their Release of Adhered Cytokines  
4.1 Introduction 
Incorporating silicone hydrogel polymers into contact lens materials solved a major 
concern in the contact lens industry.  As discussed previously, pHEMA hydrogels did not provide 
enough oxygen permeability required for lens wear longer than 24 hours.75 Due to oxygen’s 
solubility in silicone, incorporating silicone into hydrogel material allowed for an increase in 
oxygen transmissibility, which resulted in the decrease of hypoxia-related ocular conditions.83   
However, while lens-induced hypoxic conditions did decrease83, there was a 2X higher risk in 
developing CIEs with the use of silicone hydrogel lenses.107  While factors such as bacterial 
bioburden on the eyelid margins and tear film instability have been associated with the occurrence 
of CIEs in silicone hydrogel lens wearers 109, the root cause is still unknown.  
 
 In this thesis, the amount of adhered cytokines released from contact lens materials were 
quantified. The purpose of this was to be able to use this information in future studies to determine 
whether the cytokines adhered to contact lens materials were triggering an inflammatory response 
on the corneal surface. The experiments in this chapter were focused on investigating whether the 
release of cytokines differed between different contact lens materials. The results may help 
understand whether ocular inflammation and CIEs are influenced by the inherent properties of 
contact lens materials. The results between contact lens materials were compared, as protein 
deposition profiles have been reported to differ depending on the materials.59  For instance, 
amongst the four FDA lens materials groups used to describe hydrogel lens materials, Group I 
materials reportedly deposit the least amount of protein, while Group IV deposit the most.59 
Furthermore, when lens materials of high water content are compared for protein deposition, the 
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lens material with charged polymers will show greater protein deposition.121 This is due to the 
addition of electrostatic attraction present between the protein molecule and the surface (i.e. Group 
IV (high-water content, ionic lens material) will deposit higher amounts of protein in comparison 
to Group II (high-water content, non-ionic lens material)).121  
 
For the most part, the accumulation of protein, particularly lysozyme, found on silicone 
hydrogel material is less compared to that found on conventional hydrogels.139 When lysozyme 
deposition was compared between worn hydrogel (etaficon lens; 14-day daily wear lens) and 
silicone hydrogel (lotrafilcon and balafilcon; 30 day continuous wear) it was found that etafilcon 
deposited a significantly higher amount of lysozyme (985±241μg/lens) compared to lotrafilcon 
(3±1 μg/lens) and balafilcon (10±3 μg/lens).139 Due to differences in protein deposition between 
lens materials, this chapter focused on utilizing the protocol developed from the previous chapter 
to analyze two different contact lens materials: etafilcon A, an ionic hydrogel material, and 
delefilcon A, a non-ionic silicone hydrogel material. Experiments were conducted to mimic certain 
conditions of contact lens wear. 
 
The first condition of interest was to expose contact lenses to a high concentration of 
cytokines. Multiple clinical studies have analyzed the cytokines present in the tear film during 
contact lens wear under various conditions.101-103,106 In the case of ocular inflammation, such as 
Acanthamoeba keratitis there is an upregulation of cytokines on the ocular surface during contact 
lens wear. 106 Thus, to mimic an ocular environment under inflammatory conditions, contact lenses 
were soaked in a high cytokine solution. The purpose of this experiment was to determine whether 
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the release of adhered cytokines from the lens materials exposed to a high cytokine concentration 
differed between materials.  
 
The second condition that was investigated was the contact lens wear time. How long 
individuals wear contact lenses throughout the day can vary. In the previous chapter, contact lenses 
were soaked in the cytokine solution for 6 hours, thus mimicking a wear time of 6 hours. For this 
experiment, a 12-hour wear time was selected instead. The purpose of this experiment was to rather 
see whether the amount of adhered cytokines released, differed amongst lens materials if the wear 
time was increased.  
 
The third condition that was investigated was ocular temperature. In previous experiments, 
the contact lens was incubated in cytokine solutions at ambient temperature. To further understand 
how contact lens materials would respond to cytokines in an ocular setting, contact lenses were 
incubated in a cytokine solution at 34℃ to stimulate average ocular temperature. In the previous 
chapter, for protocol development, an ocular temperature of 37℃ and room temperature were 
tested. The purpose of testing a higher ocular temperature was to create parameters which would 
test extreme conditions. By doing so, it would help understand whether an increased ocular 
temperature resulted in an increase in release of cytokines from contact lens materials. However, 
for this study, the purpose was to determine whether the amount of adhered cytokines released 




4.2 Materials: Contact Lens of Interest 
A total of 2 different contact lens materials were investigated in this chapter. This consisted 
of one conventional hydrogel lens and one silicone hydrogel lens. The conventional hydrogel lens 
of interest was etafilcon A and the silicone hydrogel lens of interest was delefilcon A.   
 
4.3 Statistical Analysis  
Data in this chapter were analyzed using GraphPad Prism 8. Unpaired t-tests were 
performed to compare the amount of cytokines released by etafilcon A and delefilcon A.  Results 
were considered significant if p-value < 0.05.  Amount of cytokines released was calculated using 
Equation 3.2-1. Results are reported as mean ± SD.  
 
4.4 Incubating Contact Lens Materials in High Cytokine Concentration Solution  
4.4.1 Materials and Methods 
 
Cytokine Solution and Sample Preparation 
 
A multi-analyte lyophilized calibrator (Meso Scale Diagnostics, Rockville, MD) 
containing the cytokines, IL-1β, IL-6, IL-8, and TNF-⍺, was used.  This calibrator differs from 
that used in section 3.2.1 as this calibrator contained a total of 14 cytokines at high concentrations.  
For this study, a cytokine solution was prepared for each of the two lens types. Each calibrator was 
reconstituted in 1 mL of Diluent 2 to prepare a cytokine solution. The theoretical concentrations 
of IL-1β, IL-6, IL-8, and TNF-⍺ in the prepared cytokine solutions were reported as 5462.5 pg/mL, 
2712.5 pg/mL, 2600 pg/mL, 5312.5 pg/mL, respectively. The methodology used to prepare 
samples for this experiment followed that illustrated in Figure 3-16. A sample size of n = 4 was 
used for this study. For the control, lenses were left to incubate in a 200μL of Diluent 2 rather than 
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in a cytokine solution. Prior to testing, high cytokine solution samples underwent a 1:10 dilution 
with Diluent 2. This dilution ensured samples would be within the detection range set by the MSD 
imager.   
 
4.4.2 Results 
In this study, etafilcon A lens material released more IL-1β (127.7 ± 29.38 pg/lens) than 
delefilcon A (69.86 ± 35.74 pg/lens; p = 0.0465).  There were no significant differences between 
etafilcon A and delefilcon A with respect to the amount of IL-6 (p-value = 0.0542), IL-8 (p-value 
= 0.0924), and TNF-⍺ (p-value = 0.1477) released. The amount of cytokines released by the two 
lens type are shown in Table 4.4-a and illustrated in Figure 4-1, Figure 4-2, Figure 4-3, and Figure 
4-4. Samples were diluted prior to testing. Thus, to determine the amount of cytokines released by 
contact lens materials, concentration values provided by the MSD imager for diluted samples were 
first multiplied by 10. These values were then inserted into Equation 3.2-1.  
 
Table 4.4-a: Cytokines released by Contact Lens Material incubated in a high cytokine concentration 
solution.  
Lens Type IL-1β, pg/lens IL-6, pg/lens IL-8, pg/lens TNF - ⍺, pg/lens 
Etafilcon A 127.7 ± 29.38 51.66 ± 12.95 57.17 ± 15.51 85.68 ± 28.85 
Delefilcon A 69.86 ± 35.74 29.23 ± 13.62 33.13 ± 18.37 51.85 ± 28.74 
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Figure 4-1: Amount of IL-1β released by contact lens materials that were incubated in a high cytokine 
concentration solution. * Significance between etafilcon A and delefilcon A lens material (p = 0.0465). 
 













































Figure 4-3: Amount of IL-8 released by contact lens materials that were incubated in a high cytokine 
concentration solution. 
 












































4.5 Incubating Contact Lens Materials in a Cytokine Solution for a 12-hour period 
4.5.1 Materials and Methods 
 
Cytokine Solution and Sample Preparation  
 
A multi-analyte lyophilized calibrator containing the cytokines, IL-1β, IL-6, IL-8, and 
TNF-⍺, was used.  This calibrator was similar to the ones used in section 3.2.1.  The calibrator was 
reconstituted in 2 mL of Diluent 2 to prepare a cytokine solution of concentration 310 pg/mL, 
394.5 pg/mL, 259.5 pg/mL, and 157.5 pg/mL, for each cytokine, respectively. The methodology 
used to prepare samples for this experiment followed that shown in Figure 3-16 with one minor 
change. The lenses (n = 3 per lens type) were incubated in a cytokine solution for a 12-hour period. 
For the control, lenses were left to incubate in a 200μL of Diluent 2 rather than a cytokine solution. 
 
4.5.2 Results 
 There were no significant differences between etafilcon A and delefilcon A with respect to 
the amount of IL-1β (p = 0.5208), IL-6 (p = 0.6556) IL-8 (p = 0.4773), and TNF-⍺ (p = 0.5002) 
released.  Results were considered significant if p > 0.05.  The amount of cytokines released by 
the two lens type are shown in Table 4.5-a and illustrated in Figure 4-5, Figure 4-6, Figure 4-7, 
and Figure 4-8. Results are reported as mean ± standard deviation (pg/lens). Results were 
considered significant if p < 0.05.  
Table 4.5-a: Cytokines released by Contact Lens Material incubated in a cytokine solution for a 12-hour 
period 
Lens Type IL-1β IL-6 IL-8 TNF - ⍺ 
Etafilcon A 4.222 ± 0.9722 5.712 ± 1.431 3.350 ± 0.7627 1.437 ± 0.2818 
Delefilcon A 5.501 ± 2.998 6.802 ± 3.656 4.579 ± 2.607 1.881 ± 0.9992 
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Figure 4-5: Amount of IL-1β released by contact lens materials that were incubated in a cytokine solution 
for a 12-hour period. 
 
Figure 4-6: Amount of IL-6 released by contact lens materials that were incubated in a cytokine solution for 







































Figure 4-7: Amount of IL-8 released by contact lens materials that were incubated in a cytokine solution for 
a 12-hour period. 
 
Figure 4-8: Amount of TNF-⍺  released by contact lens materials that were incubated in a cytokine solution 





































4.6 Incubating Contact Lens Materials in a Cytokine Solution at 34℃ 
4.6.1 Materials and Methods 
 
Cytokine Solution, and Sample Preparation  
 
A multi-analyte lyophilized calibrator containing the cytokines, IL-1β, IL-6, IL-8, and 
TNF-⍺, was used.  This calibrator was similar to the ones used in section 3.2.1. The calibrator was 
reconstituted in 2 mL of Diluent 2 to prepare a cytokine solution of concentration 310 pg/mL, 
394.5 pg/mL, 259.5 pg/mL, and 157.5 pg/mL, for each cytokine, respectively. The methodology 
used to prepare samples for this experiment followed that shown in Figure 3-16 with one minor 
change. The lenses (n = 3 per lens type) were incubated in a cytokine solution at 34℃ with shaking. 
For the control, lenses were left to incubate in a 200μL of Diluent 2 rather than a cytokine solution.  
 
4.6.2 Results 
There were no significant differences between etafilcon A and delefilcon A with respect to 
the amount of IL-1β (adjusted p-value = 0.7205), IL-6 (adjusted p-value = 0.5868), IL-8 (adjusted 
p-value = 0.7403), and TNF-⍺ (adjusted p-value = 0.6624) released.  The amount of cytokines 
released by the two lens type are shown in Table 4.6-a and illustrated in Figure 4-9, Figure 4-10. 
Figure 4-11, and Figure 4-12. Results are reported as mean ± standard deviation (pg/lens). Results 
were considered significant if p < 0.05.  
Table 4.6-a: Cytokine released by contact lens materials incubated in a cytokine solution at 34℃. 
Lens Type IL-1β, pg/lens 
 
IL-6, pg/lens IL-8, pg/lens TNF-⍺, pg/lens 
Etafilcon A 3.298 ± 1.543 4.346 ± 1.897 2.608 ± 1.139 1.140 ± 0.5605 
Delefilcon A 2.905 ± 0.8693 3.619 ± 0.9778 2.331 ± 0.7283 0.9656 ± 0.3144 
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Figure 4-9: Amount of IL-1β released by contact lens materials incubated in a cytokine solution at 34℃. 
 











































Figure 4-11: Amount of IL-8 released by contact lens materials incubated in a cytokine solution at 34℃. 
 












































In this chapter, the experiments conducted focused on determining whether there was a 
significant difference between lens materials with respect to the amount of adhered cytokines 
released by lens materials exposed to different conditions. The lens materials of interest were 
conventional hydrogel, etafilcon A, and silicone hydrogel, delefilcon A.  
 
The first experiment conducted focused on incubating contact lens materials in a high 
cytokine concentration solution, as cytokine levels are substantially upregulated during 
inflammation compared to basal levels. Thus, testing under these conditions stimulated a contact 
lens wear during an inflammatory response. As mentioned previously, multiple factors influence 
protein adsorption onto lens materials.  With a higher concentration of cytokines present in the 
solution, there is a possibility for competitive binding between the cytokines. It may be that at 
higher concentrations, cytokines with a higher affinity more easily displace the cytokines which 
have a lower affinity for the lens material.  
 
 The results in section 4.4.2 show that there was a significant increase in the amount of IL-
1β released by the etafilcon A lens in comparison to delefilcon A (p = 0.0465). While there was 
no significant increase for the other three cytokines, graphically, a similar pattern is observed. 
Although it is evident that etafilcon A released more cytokines than delefilcon A, the differences 
between the results may be due to the amount of cytokines that were initially adhered to the contact 
lens materials. It has been reported in the literature that pore size, among various other factors, 
may affect protein uptake by the contact lens materials.60 With lens materials, larger pore sizes are 
associated with higher water content.140 While etafilcon A is classified as a high-water content 
material, delefilcon A’s water content is described to be a gradient. While the surface is greater 
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than 80%, the core of the lens is 33% water.122,123 It could be that Etafilcon A was able to uptake 
more cytokines due to its larger pore size in comparison to the Delefilcon A lens. As a result of 
more proteins adsorbed, the Etafilcon A lens may have been able to release more cytokines which 
is shown in Figure 4-1.   
 
 The second experiment conducted focused on examining whether there were significant 
differences between lens materials for the amount of adhered cytokines released by lens materials 
exposed to cytokines for 12 hours. The purpose of this experiment was to mimic longer lens wear 
using the in vitro model. However, as seen in section 4.5.2 there was no significant difference 
between the amount of cytokines released by etafilcon A and delefilcon A (p > 0.05). A factor that 
may have affected the release of cytokines is protein denaturation.  Protein denaturation can be a 
consequence of the protein adhering to a surface or material. For instance, lysozyme deposited 
onto lens materials have been found to be denatured.139 With the prolonged incubation period, the 
cytokines may have denatured over time and thus were not able to be released from the lens 
material. Thus, with a longer soaking time for cytokine uptake (12-hours), there was no difference 
in the amount of adhered cytokines released by the lens materials.  
 
The third experiment conducted focused on examining whether significant differences 
between lens materials for the amount of adhered cytokines released by lens materials exposed to 
cytokines at 34℃ (ocular temperature).   The purpose of this experiment was to mimic lens wear 
by incubating it in a cytokine solution at ocular temperature. The change in temperature affects the 
equilibrium water content of a contact lens material.141 In fact, the increase in water content can 
lead to an increase in the amount of protein adsorbed.121 By incubating the contact lens material in 
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a cytokine solution at a higher temperature, there was a possibility for the lens to adhere more or 
fewer cytokines and as a result release more or fewer cytokines.  However, as seen in section 4.6.2, 
there was no significant difference between the lenses with respect to the amount of cytokines they 
released.   
 
In this chapter, one study showed that there is a significant difference between contact lens 
materials with respect to the amount of IL-1β released when incubated in a high cytokine 
concentration solution. The remainder of the studies showed that there was no significant 
difference between the materials with respect to the amounts of cytokines released. However, the 
results do demonstrate that contact lens materials exposed to various conditions can adsorb 
cytokines and release them as well.  
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Chapter 5: Investigating the Differences Between Protein Coated 
Conventional and Silicone Hydrogel Lens and Their Release of Adhered 
Cytokines 
5.1 Introduction  
The purpose of chapter 4 was to determine whether adhered cytokine concentrations 
differed between contact lens materials under various ocular conditions using the protocol 
prepared in chapter 3. In these experiments, lenses were free to interact with cytokines with 
minimal interference. Interaction between cytokines and lenses were minimized to the 
inflammatory markers present in the calibrator blend. When a contact lens is inserted into the eye, 
the environment it is introduced to is much different. It has been well established that once a 
contact lens is inserted into the eye, it adsorbs various tear proteins and lipid molecules.139,142-144 
Protein molecules which are adsorbed onto contact lens materials include lysozyme145,146, 
lactoferrin146,147, lipocalin-1146, immunoglobulin G148, and etc.    
 
 Due to lysozyme, lactoferrin, and albumin being three of the most abundant proteins found 
in the tear film, their deposition onto contact lens materials has been thoroughly investigated. The 
adsorption and movement of protein into the matrix of the contact lens material is largely due to 
the surface charge and water content of the lens material.121 While several studies have investigated 
individual protein deposition profiles onto contact lens materials, one study observed the 
competitive adsorption between proteins onto lens materials. When the competitive adsorption 
between lysozyme and lactoferrin on silicone hydrogel materials was examined, it was found that 
the results varied depending on the material.147  For instance, while lysozyme and lactoferrin 
deposition on lotrafilcon B was affected by competitive adsorption, deposition on senofilcon A 
and balafilcon A was not.147  In another study, researchers analyzed the deposition of albumin on 
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the lysozyme-coated contact lens and found that etafilcon A material deposited significantly lower 
amounts of albumin onto lysozyme coated lenses (58 ± 12 ng/lens) compared to uncoated lenses 
(84 ± 5 ng/lens; p = 0.02).149   
 
 The purpose of the experiments conducted in this chapter was to study the release of 
adhered cytokines from lysozyme, lactoferrin, or albumin coated lenses. Whether or not results 
differed between contact lens materials was also determined. The lens materials of interest in this 
study were etafilcon A, an ionic hydrogel material, and delefilcon A, a non-ionic silicone hydrogel 
material. 
 
5.2 Materials and Methods 
Contact lens of interest and Cytokine Solution 
 
A total of 2 different contact lens materials (n = 3 for each lens material in each condition) 
were investigated in this study. This consisted of one conventional hydrogel lens (etafilcon A) and 
one silicone hydrogel lens (delefilcon A). A multi-analyte lyophilized calibrator containing the 
cytokines, IL-1β, IL-6, IL-8, and TNF-⍺ was used.  The calibrator blend used in this study was the 
high cytokine concentration blend. This blend was also used in section 4.4.1. For this study, a 
cytokine solution was prepared for each of the two lens types.  Each cytokine solution was prepared 
by pooling two calibrator blends (reconstituted with 1.5 mL of Diluent 2 each) together. Thus, 
each cytokine solution prepared for each lens type had a final volume of 3 mL. The theoretical 
concentrations of IL-1β, IL-6, IL-8, and TNF-⍺ in each solution were 3641.67 pg/mL, 1808.33 
pg/mL, 1733.33 pg/mL, and 3541.67 pg/mL, respectively. For the control solution, lenses were 
soaked in 200μL of Diluent 2 rather than in a cytokine solution.   
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Lysozyme, Lactoferrin and Albumin preparation  
 
 The proteins of interest in this study were lysozyme, lactoferrin, and albumin. The 
concentrations of the prepared protein solutions were as followed: 1.9 mg/mL of lysozyme 
(Lysozyme from chicken egg; Sigma Aldrich, Oakville, ON), 1.9 mg/mL of lactoferrin (Lacromin- 
Recombinant Human Holo Lactoferrin; InVitria, Junction City, KS) and 0.5 mg/mL of albumin 





Contact lenses were removed from their packaging solution and were immediately rinsed 
in PBS solution. The excess PBS solution was removed from the lens by holding the lenses against 
lens paper. The lenses were then individually placed into polypropylene tubes containing 1mL of 
either a lactoferrin, albumin, or PBS solution. For the lysozyme solution, a volume of 6mL and 
1.5mL was used for etafilcon A and delefilcon A lenses, respectively. Individual lenses were 
incubated in the protein solutions at room temperature for 16 hours with shaking. There were two 
control solutions prepared in this study. A lens from each lens type was incubated in 1mL of PBS 
to later be incubated in a cytokine solution (to compare the release of cytokines from a lens with 
no protein coat) or a diluent 2 solution (to calculate background data). At the end of the 16-hour 
incubation period, lenses were rinsed twice in a PBS solution.  The lenses then underwent the 
finalized procedure mentioned in Figure 3-16 using the prepared cytokine solution. Prior to testing, 
high cytokine solution samples underwent a 1:10 dilution with Diluent 2. 
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5.3 Results and Statistical Analysis 
The amount of adhered cytokines released by various protein-coated contact-lens are 
described in Table 5.3-a, Table 5.3-b, Table 5.3-c, and  
Table 5.3-d. Results are also illustrated in Figure 5-1, Figure 5-2, Figure 5-3 and Figure 
5-4. Samples were diluted prior to testing. Thus, to determine the amount of cytokines released by 
contact lens materials, concentration values provided by the MSD imager for diluted samples were 
first multiplied by 10. These values were then inserted into Equation 3.2-1. A two-way ANOVA 
statistical test was conducted with lens type and protein as factors. Tukey’s multiple comparisons 
test was undertaken to compare results within a single lens type and a Sidak’s multiple 
comparisons test was undertaken to compare results between lens types. There was no statistically 
significant difference between the lens materials with respect to the amount of cytokines released 
(p > 0.05). There was also no significant difference within a lens material with respect to the 
different proteins it was coated with (p > 0.05).  Results were considered significant if p < 0.05.   
Table 5.3-a: IL-1β released by protein-coated contact lens materials (pg/lens) 
Lens Type Lysozyme Lactoferrin Albumin PBS 
Etafilcon A 87.035 ± 23.100 38.293 ± 17.517 63.382 ± 19.774 77.139 ± 30.342 
Delefilcon A 83.692 ± 72.139 84.622 ± 30.410 73.500 ± 35.651 66.183 ± 6.465 
Adjusted p-value >0.9999 0.4026 0.9943 0.9923 
 
 
Table 5.3-b: IL-6 released by protein-coated contact lens materials (pg/lens) 
Lens Type Lysozyme Lactoferrin Albumin PBS 
Etafilcon A 39.900 ± 9.580 19.251 ± 8.475 30.958 ± 9.267 37.622 ± 12.378 
Delefilcon A 42.688 ± 35.121 41.021 ± 13.447 39.286 ± 16.875 35.765 ± 2.692 
Adjusted p-value 0.9993 0.4005 0.9547 0.9999 
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Table 5.3-c: IL-8 released by protein-coated contact lens materials (pg/lens) 
Lens Type Lysozyme Lactoferrin Albumin PBS 
Etafilcon A 36.709 ± 10.699 17.013 ± 7.899 28.643 ± 9.290 33.550 ± 11.919 
Delefilcon A 39.780 ± 35.502 37.428 ± 14.740 33.805 ± 16.008 30.731 ± 1.723 
Adjusted p-value 0.9990 0.4682 0.9924 0.9993 
 
Table 5.3-d: TNF-⍺ released by protein-coated contact lens materials (pg/lens) 
Lens Type Lysozyme Lactoferrin Albumin PBS 
Etafilcon A 77.148 ± 20.058 36.805 ± 16.938 58.242 ± 19.253 69.278 ± 27.266 
Delefilcon A 79.676 ± 70.776 77.672 ± 30.320 72.467 ± 32.278 61.505± 5.805 
Adjusted p-value >0.9999 0.4803 0.9761 0.9976 
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Figure 5-2: Amounts of IL-6 released by lysozyme, lactoferrin, albumin or PBS coated contact lens 
materials 








































Figure 5-4: Amounts of TNF-⍺ released by lysozyme, lactoferrin, albumin or PBS coated contact lens 
materials 
 


































In this chapter, the conducted studies showed the amount of cytokines released by contact 
lens materials that were coated with lysozyme, lactoferrin, albumin, or the control, PBS. The 
contact lens materials of interest were an FDA group IV lens material, etafilcon A, and a group V 
lens material delefilcon A. Multiple factors such as the surface charge and water content of the 
lens material, the temperature, and pH of the solution, and protein characteristics can all influence 
protein adsorption.136 This in return will affect the release of proteins from the lens material.  
 
 In this study, it was of interest to determine whether delefilcon A would release more or 
fewer cytokines in comparison to etafilcon A lens material when pre-coated with various proteins. 
It was also of interest to determine whether the type of protein coat influenced the release of 
cytokines within a single lens type. However, as the results in section 5.3 demonstrate, there was 
no significant difference between the two lens materials with respect to the amount of cytokines 
released. While both lenses have different characteristics, in terms of ionicity, where etafilcon A 
is a negatively charged ionic material and delefilcon A is a non-ionic material, it was interesting 
to find that both materials released cytokines in a similar manner. Protein adsorption is dependent 
on the affinity of a protein for the lens surface. As results show in section 5.3, there was also no 
significant difference between the amount of cytokines released by the lens materials, regardless 
of whether the lenses were coated with a protein (lysozyme, lactoferrin, albumin) or not (PBS). 
Both etafilcon A and delefilcon A may have a higher affinity for the coated proteins and as a result, 
displacement of these proteins by cytokines did not occur.  
 
These results illustrate that cytokines are released by both lens materials irrespective of the 
other proteins adsorbed to the lens.  This indicates how cytokines may be released in an ocular 
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environment. In the ocular environment, while the lens may be deposited with various other 
proteins, these depositions may have minimal effects on the release of adhered cytokines.  
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Chapter 6: Conclusions and Future Work 
6.1 Summary 
This thesis adds to the current discussion surrounding contact lens wear and its impact on 
ocular inflammation. Biomarkers found in tears can be used to analyze ocular conditions such as 
dry eye disease150,151, keratoconus152, ocular discomfort, and corneal infiltrative events caused by 
contact lens wear.89,119 Experimental studies have explored the connections between cytokine 
levels and tear samples from contact lens wearers, but minimal research has been conducted to 
determine whether cytokines adhered to contact lens materials also impact the tear film of contact 
lens wearers. While risk factors such as wear modality, gender, ocular, and general health have 
been found to be associated with contact lens-related CIEs153, the role of cytokines adsorbed by 
lens materials is unclear.  The experiments conducted in this thesis sought to determine whether 
the release of adhered cytokines on lenses differed between lens materials. Information on the 
amount of cytokines released by the lens may provide an insight into whether lens wear has the 
potential to induce an inflammatory response.   
 
 This thesis focused on three objectives: 1) develop a protocol that would aid in quantifying 
the amount of adhered cytokines released by contact lens materials; 2) determine whether the 
release of cytokines differed between contact lens materials that were pre-exposed to various 
ocular conditions; and 3) determine whether the release of cytokines differed between protein-
coated (lysozyme, lactoferrin or albumin) contact lens materials.  
 
 In chapter three, the parameters for a protocol to quantify the released cytokines were set 
after examining the effects of changing temperature, incubation period, and volume of diluent 2 
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followed by determining which change would be best suitable. The finalized protocol involved 
incubating cytokine-adsorbed contact lenses in 550μL of diluent 2 for 1 hour at room temperature.  
 
 The outline of the protocol developed in chapter three was adapted from a study conducted 
by Mann and Tighe in 2007.133  In their study, they focused on analyzing proteins present in the 
tear envelope.  The tear envelope was defined to be a small layer of tear film which enclosed the 
contact lens material the moment it was removed from the lens wearer’s eyes.133  The purpose of 
this was to further understand the relationship between tear film composition and the contact lens 
surface.  For the studies conducted in this thesis, while the protocol from the study conducted by 
Mann and Tighe was adapted, the definition of the “tear envelope” was slightly changed.  In the 
studies conducted in this thesis, the focus was to quantify the adhered cytokines released by the 
contact lens materials.  Due to protocol limitations, it was difficult to determine whether cytokines 
were adhered to the surface or the matrix of the lens materials. Thus, rather than focusing primarily 
on the surface of the lens material, the focus was shifted to analyzing and quantifying the amount 
of cytokines released by the entire lens material.  Thus, this included quantifying cytokines present 
in the small layer of cytokine solution surrounding the contact lens material, as well as that present 
in the matrix of the lens.   
 
In order to investigate the amount of cytokines present in the “tear envelope” defined by 
Mann and Tighe, alterations would have to be made to the protocol developed in chapter three. In 
a study conducted by VanDerMied et al., it was concluded that Schirmer strips may be used to 
quantify cytokines and MMPs from tear samples.154  Perhaps, this technique may also be used to 
assess the quality of the “tear envelope” present around the contact lens materials. Once contact 
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lens materials are removed from the cytokine solution, a Schirmer strip may be used to dab the 
surface of the contact lens materials to remove the “tear envelope”. Then, using an appropriate 
extraction buffer, cytokines can be extracted from the Schirmer strip and later be quantified using 
an immunoassay.  This procedure may provide an overall estimation regarding the quantity and 
type of cytokines present in the tear envelope.   
 
Protein deposition profiles on lens materials can often be predicted using the characteristics 
(e.g. surface charge) of both the protein molecules and the lens materials. In this thesis, four 
cytokines (IL-1β, IL-6, IL-8 and TNF-⍺) and their interaction with two lens types, etafilcon A and 
delefilcon A, were assessed.  
 
 The charge of a protein molecule may depend on the pH of the solution in which it is 
present. In the studies conducted in this thesis, the solution used to collect the released cytokines 
from contact lens materials was Diluent 2.  Diluent 2, as described by the MSD scientific support 
group, is a proprietary PBS solution with a pH of ~ 7.4.  Using this pH value, as well as the pI 
points of the various cytokines, the charge of the cytokines can be predicted. The pI points of IL-
1β, IL-6, and TNF-⍺ (~ 5.8, ~ 6, ~ 6.9 respectively, as per MSD Scientific Support) are all below 
the pH of the diluent 2 solution. Thus, these cytokines are expected to be negatively charged in the 
calibrator solution. Meanwhile, IL-8 has a pI point of ~ 8.5 (as per MSD Scientific Support). Due 
to this value being greater than the pH of the diluent 2 solution, IL-8 is expected to possess a 
positive charge. Using this information, from a charge perspective, the cytokine’s affinity for the 
different lens materials may be predicted. Now, while etafilcon A is a negatively charged lens 
material, delefilcon A is a non-ionic hydrogel and thus its interaction with cytokines may not be 
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due to electrostatic attractions. However, with etafilcon A lenses, due to its negatively charged 
character, it can be predicted that this particular lens material may have a stronger attraction for 
IL-8 and weaker attraction for the negatively charged IL-1β, IL-6, and TNF-⍺. The interaction 
between the cytokines and lens material due to charge could have impacted the results attained in 
this thesis in multiple ways. For example, with a weaker electrostatic attraction, etafilcon A lens 
materials may have been able to release a greater amount of IL-1β, IL-6, and TNF-⍺ compared to 
IL-8. Or, perhaps due to a greater electrostatic attraction for IL-8, etafilcon A lens materials may 
have been able to adhere to IL-8 more than IL-1β, IL-6, and TNF-⍺.  This in return may have 
resulted in a higher release of IL-8 due to there being a higher concentration of this particular 
cytokine being present in the matrix of the lens material.  From an adherence perspective, it can 
be predicted that etafilcon A lens material may have adsorbed more IL-8 in comparison to IL-1β, 
IL-6, and TNF-⍺.  
 
 Another factor that may influence the interaction between cytokines and lens materials is 
the pore size of the contact lens material and the size of the cytokines.  It has been noted in literature 
that the pore size of lens material may be associated with its water content.140 With greater water 
content, the lens material may have larger pore sizes.140,155 Due to its high-water content, etafilcon 
A lens materials can be expected to have larger pore sizes in comparison to delefilcon A lens whose 
water content is described to behave in a gradient pattern (core: 33%; surface >80%).122,123 With 
its larger pores, etafilcon A may allow for cytokines to travel further into its matrix in comparison 
to delefilcon A. As a result, the total amount of cytokines released by both lens types may vary. 
For instance, due to etafilcon A’s ability to adsorb more cytokines, it may in return release more 
cytokines than deleficon A. 
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 Pore sizes may also influence the type of cytokine that may be allowed to travel through 
the matrix of the lens. For example, when compared to the other cytokines investigated in this 
thesis, IL-8 is a relatively small cytokine. As seen in Table 2.3-a, it has a molecular weight of 8 
kDa. With a relatively small molecular weight, IL-8 may be expected to travel further and more 
easily through the core of the lens material in comparison to a larger cytokine such as IL-6 (20.3 
kDa).  Using cytokine sizes and lens pore sizes as factors, it can be predicted that a higher 
concentration of IL-8 may be adsorbed and thus released by etafilcon A lens in comparison to IL-
6. Due to their similarities in molecular weights, IL-1β and TNF-⍺ (17 and 17.5 kDa, respectively) 
can be expected to behave similarly with respect to how far it may penetrate into the etafilcon A 
lens material.   
 
 Although multiple factors influence the adsorption and release of proteins to contact lens 
materials, the most commonly discussed factor is the surface charge of both the protein molecule 
and the lens material of interest. While electrostatic attractions can be used to predict protein 
deposition patterns, there are cases where it is not as direct. For instance, pHEMA lenses that are 
incorporated with MA (a negatively charged group) are found to deposit a higher level of lysozyme 
(a positively charged protein) due to the electrostatic attraction between them.136 However, protein 
deposition can still occur despite the surface of the protein and material holding similar charges. 
The adsorption of a negatively charged protein molecule onto a negatively charged material can 
be encouraged if there are portions of positively charged areas present on the material.136 Proteins 
also have the ability to re-arrange their structure when they come into contact with synthetic 
surfaces.141  To remain in a soluble state in an aqueous solution, proteins fold such that their non-
polar amino acid groups are tucked in, on the inner side of the protein structure, and the polar 
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amino acid groups are found on the outer surface.141 However, this arrangement can change 
depending on the properties of the synthetic surface to which it is exposed.  When a protein 
molecule comes into contact with a hydrophobic surface, the molecule may re-fold into an 
arrangement that allows for its non-polar amino acid groups to interact with the hydrophobic 
surface, and for the hydrophilic amino acid groups to interact with and face the direction of the 
solvent.141 If a hydrophilic surface is presented, re-arrangement occurs in a manner where the non-
polar amino acid groups are tucked inside the protein structure, and the outer surface is composed 
of polar amino acids which are then free to interact with the hydrophilic surface through hydrogen 
bonds and salt-bridge associations.141 This re-folding process may explain the results seen in 
chapter four. Aside from the significant increase in the release of IL-1β by etafilcon A compared 
to delefilcon A from section 2.2.2, there was no significant difference between the amount of 
cytokines released between the etafilcon A and delefilcon A lens materials.  With a re-arrangement 
in structure, the adsorption of cytokines onto both materials may have been favoured such that 
irrespective of charge, both lens materials released cytokines in similar manners.  
 
 The experiments conducted in chapter 5 focused on the interaction between cytokines and 
protein-coated contact lens materials. The three proteins of interest were: lysozyme, lactoferrin, 
and albumin. The  literature shows that an initial protein coating has the ability to influence the 
subsequent protein adhesion.144  For instance, a lysozyme-coating has been reported to reduce the 
subsequent adsorption of albumin onto etafilcon A lens material.149  In a protein solution, proteins 
possessing a higher affinity for the material will bind onto its surface.144  The increase in protein 
deposition can reduce the hydrophilicity or hydrophobicity of a material depending on its initial 
state.144 This change then allows for it to attract protein molecules it was not attracted to 
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previously.144 As the deposition of the subsequent protein molecule increases, the material begins 
to lose its affinity for the first protein molecule, decreasing its deposition in return.144 Keeping this 
mechanism in mind, it was of interest to determine whether the presence of a protein layer 
influenced the release of subsequently adhered cytokines. The results from this chapter showed 
that the effects of a lysozyme coat on etafilcon A and delefilcon A lens materials were similar to 
those of a lactoferrin, albumin, and a PBS coat. It was demonstrated that the presence or absence 
of a protein coat did not influence the release of cytokines from lens materials. As well, neither 
did the composition of the lens material. 
 
HEMA, the major monomer found in etafilcon A81  is hydrophilic in nature.156 Thus, 
etafilcon A material is projected to possess hydrophilic properties. Delefilcon A is an FDA group 
V lens (silicone hydrogel). However, due to its water gradient technology, the composition of the 
core of the material varies from that present on the surface.  While the core of delefilcon A 
encompasses a low water content silicone hydrogel material, its surface is composed of hydrophilic 
polymers which include polyamidoamide and poly(acrylamide-acrylic) acid.156  When surface 
levels of silicon were measured in various silicone hydrogel lens materials, the lowest percentage 
of silicon was found in delefilcon A and lotrafilcon A.156  Since silicon is hydrophobic in nature, 
the lack of surface-expressed silicon found in delefilcon A156 may cause it to have less hydrophobic 
properties on its surface. With a hydrophilic surface and a lack of silicon,156 it is possible that 
delefilcon A interacted with cytokines similarly to etafilcon A. This resulted in both materials 
releasing similar levels of cytokines. 
  
 93 
 The effects of contact lens materials on tissue-grown corneal epithelial cells have been 
investigated, and it was found that the presence of lens materials did not greatly influence or affect 
cytokine production.157 It was concluded that the direct interaction between the contact lens and 
the corneal epithelial cells is unlikely to induce the production of inflammatory markers.157 With 
the cause of adverse events due to contact lens wear still in question, the cytokines released from 
contact lens materials may be inducing an inflammatory response. The results from this thesis 
provide evidence that cytokines can be released from contact lens materials. It is unknown, 
however, if this release occurs over some time, or at once. In the case that there is a burst of 
cytokines from lens materials, the ocular immune system may recognize it as an inflammatory 
response. For instance, IL-1β is known to trigger inflammatory responses.41 In the case that IL-1β 
is released from lens materials into the tear film at once, inflammatory cells may be recruited to 
the site of infection and the upregulation of subsequent cytokines in the inflammatory cascade may 
be initiated.158 If cytokines are released over time, with the constant recruitment of inflammatory 
cells to the surface of the cornea, the cells may aggregate, and that may lead to the eventual 
production of CIEs.  
 
 As shown in Table 2.3-a, there is a large range in basal levels of cytokines found in tears.  
Disruption to homeostatic levels of cytokines may be enough to induce an inflammatory response, 
as there is no clear level of inflammatory markers required to cause inflammation. For an 
individual whose basal level of IL-1β is 436.3 pg/mL47, a release of 3.298 pg (from Table 4.6-a) 
may not disrupt homeostatic levels and lead to an inflammatory response. However, individuals 
whose average basal level of IL-1β  is 7.42 pg/mL132, the addition of 3.298 pg may be recognized 
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by the host defense system as an inflammatory response, consequently leading to an upregulation 
of subsequent cytokines.   
 
 While the results do not provide much evidence of lens material-dependent cytokine 
release or sufficient reason for why there exists a two-fold increased risk in developing CIEs with 




The experiments conducted in this thesis did have various limitations. While the 
experiments focused on the amount of cytokines released, the amounts adsorbed before their 
release were not measured. This information would have aided in determining the efficiency of the 
protocol developed in chapter 3.  In addition, it may have also indicated whether lens materials 
had the ability to release all adsorbed cytokines. Details with regards to the amount of cytokines 
adsorbed may also help determine the kinetics of cytokine release from lens materials. While both 
lens materials in chapters four and five seem to have released similar amounts of cytokines, it is 
unknown what percentage of cytokines were released from each material. As an FDA group IV 
lens material, etafilcon A has the potential to deposit a large amount of proteins.121 It is possible 
that while delefilcon A released a large portion of adhered cytokines, etafilcon A may have 




Due to the limitations present in the studies conducted, it was also difficult to determine 
the direct relationship between charge and pore size of lens material and the release of cytokines. 
To further understand this relationship, the following studies may be performed.  Firstly, it would 
be of interest to use a calibrator blend that contained one particular type of cytokine as opposed to 
a blend containing multiple cytokines (as used in this thesis). Next, to investigate the role a 
cytokine’s charge had on its release from lens materials, it would be of interest to study the release 
of IL-8 (a positively charged cytokine in diluent 2) from an ionic lens material such as etafilcon A 
and a non-ionic lens material such as omafilcon A. Theoretically, due to its negative surface 
charge, etafilcon A should release a lower concentration of IL-8 in comparison to omafilcon A.  If 
there is a great difference in results, the impact of the electrostatic attraction between the lens 
material and cytokine will be known. Then, to analyze the role a cytokine’s molecular weight has 
on its release from lens materials, it would be of interest to study IL-8 (8 kDa) and IL-6 (20.3 kDa) 
and its interaction with a non-ionic lens material that has a relatively large pore size such as 
omafilcon A. The purpose of using a non-ionic lens material is to not allow for difference in 
charges to influence the final result.  Results from this study may provide details with regards how 
the difference in molecular weight influences a proteins ability to be released by lens materials. 
  
The primary focus of chapter 3 was to develop a protocol that would assist with quantifying 
the number of adhered cytokines released by contact lens materials. However, the process of 
developing a protocol was met with its limitations.  
 
 Firstly, there were three variables of interest in chapter three. For each variable, two 
conditions were tested using four lens types. For these studies, a sample size of three lenses per 
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lens material per testing condition was used.  Due to the novelty of the study, there were minimal 
studies available in literature expressing appropriate sample sizes for such experiments. Thus, 
taking cost and supplies into consideration, a sample size of three was chosen. However, a small 
sample size may have impacted the statistical analysis.  For instance a small sample size may cause 
the study to have low power.159  One possible consequence of a study having low power  is that 
the study may produce false negative results.159  With low power, statistical differences between 
testing conditions such as temperature (room temperature vs 34 ℃) may not be detected. Hence, 
increasing the sample size to four may increase the power of the study. As a result, there may be 
less variability in the results and the statistical impact due to sample size will decrease.  
 
 Next, there was a limitation placed on an intermediate step in this study.  In chapter three, 
lens materials were soaked in a cytokine solution.  Post the incubation period, tweezers were used 
to remove the lens materials and the lenses were then immediately placed into a 0.6μL tube filled 
with diluent 2.  This condition introduced the possibility of the lenses transporting excess solution 
in addition to adhered cytokines. To minimize solution transfer, contact lens materials were held 
against the side of the polypropylene tube to drain excess solution. However, this process does not 
eliminate the possibility of transferring solution completely.  In this scenario, it is possible that the 
cytokines quantified may have also come from the solution surrounding the lens material in 
addition to those that were originally adhered to the lens.  For future studies, in order to reduce the 
transfer of excess solution, it would be appropriate to rinse the lenses in a PBS solution the moment 
the lenses are removed from the cytokine solution. Once the excess solution is removed from the 
lens, the lenses may then be placed into the 0.6μL microcentrifuge tube. With this additional 
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rinsing step, the source of the cytokines in the final eluate can be narrowed down to the lenses 
rather than the lenses and excess solution.  
 
 In this study, a lyophilized calibrator blend prepared by Meso Scale Discovery was used.  
The blend used in chapter three contained a total of ten cytokines, four of which were quantified 
in this thesis. In this blend, the initial concentration of the cytokines varied.  For example, as seen 
in section 3.2.1 the theoretical concentration of IL-1β, IL-6, IL-8, and TNF-⍺ in the prepared 
cytokine solution were reported as 88.57 pg/mL, 112.71 pg/mL, 74.14 pg/mL and 45 pg/mL, 
respectively. Any result that implied an increased release of one cytokine over another may 
primarily be due to the unequal distribution of the cytokines in this blend rather than the lens 
materials having a higher affinity for one cytokine over another.   
 
The application of the protocol is also limited by the variables investigated during protocol 
development. In chapter 3, three variables were investigated and for each variable, two conditions 
were tested.  To develop a protocol, it would be optimal to test multiple conditions prior to deciding 
on a most suitable protocol. For example, to determine the incubation period, 0-hours and a 1-hour 
incubation times were tested. It is unknown whether incubating the lens for a longer period of time, 
such as 24 hours, would result in a greater release of cytokines. While testing multiple time periods 
would assist in determining optimal conditions, it was not feasible given my timelines for 
completion.   
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6.3 Future Work 
In this thesis, there was a focus on examining the release of protein inflammatory markers, 
specifically cytokines, from contact lens materials. Due to their key role in ocular inflammation 
the cytokines of interest were:  IL-1β, IL-6, IL-8 and TNF-⍺.  However, several other cytokines 
and chemokines also have crucial roles in the ocular inflammatory process. Increased levels of IL-
17A have been found in contact lens wearers who experienced contact lens discomfort89, so 
determining the levels of IL-17A released by lens materials would be beneficial as well.  Similarly, 
increased levels of MMP-9 were found in those who wore reverse geometry contact lens, but not 
in those who wore silicone hydrogel lens or no lens.103  Hence, it would also be of interest to study 
MMP-9 levels as well.  
 
Several studies in literature have reported that the risk of developing CIEs from silicone 
hydrogel contact lens wear is two times higher than in lower oxygen permeable contact lenses.109-
111  The purpose of the studies conducted in this thesis was to investigate whether the release of 
cytokines differed between conventional and silicone hydrogel lens material. If so, the increased 
risk of developing CIEs with silicone hydrogel lens may be due to it releasing more cytokines and 
thus inducing CIEs.  While that was the focus of this thesis, there was a limitation placed on the 
conclusions that could be drawn.  In the studies conducted, there was a focus placed on daily 
disposable lenses.  However,  the higher risk of developing CIEs with silicone hydrogels was seen 
with extended wear lenses (worn for a 30 day period in comparison to the lower oxygen permeable 
lenses worn for 7 days).107  Under these conditions, the exposure time of cytokines and tear film 
to lenses may have played a role in inducing CIEs onto the corneal surface. To mimic such 
conditions, and further understand how extended wear silicone hydrogel lenses may influence CIE 
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development, minor changes can be made to the protocol developed in chapter three. Firstly, rather 
than incubating contact lens in a cytokine solution for a 6-hour period, perhaps the incubation 
period can be extended to 7-14 days.  In addition, every 24 hours, a 50μL sample of the cytokine 
solution should be collected. Following the incubation period, the lenses should undergo the 
cytokine removal process.  The results from this study may help understand whether cytokine 
deposits accumulate onto the lens overtime, and whether there exists a maximum amount of 
cytokines that can be adhered to and thus released by lenses.  The purpose of collecting a 50μL 
sample of the cytokine solution every 24 hours is to observe whether cytokines are being released 
back into the solution by the lenses over the incubation period.  If the concentration of the cytokines 
decreases overtime, it may be due to the lens adsorbing the cytokines.  However, if the 
concentration of cytokines plateaus over a period of time, it may be due to the lens’s inability to 
adsorb any additional cytokines due to saturation. Alternatively, if the cytokine concentration 
fluctuates, it may be due to the process of adsorption and release reaching equilibrium.  The results 
from these studies may help further understand how extended lens wear influences the release of 
cytokines by lens materials.  
 
This thesis focused on in vitro studies to provide an insight into the amount of cytokines 
released by contact lens materials. With the protocol developed in chapter 3, future studies could 
aim to determine the amount of cytokines released by patient-worn lenses. Perhaps, this may aid 
in quantifying the amounts of cytokines released back into the tear film.  A comparison between 
the amount of cytokines present in post-lens wear tears and the amount released from patient-worn 
lenses may answer whether the upregulation of inflammatory markers during contact lens wear is 
caused by an inflammatory response due to the released cytokines. 
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